BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Domper Arnal MJ, Ferrández Arenas &, Lanas Arbeloa &. Esophageal cancer: Risk factors, screening and endoscopic treatment in Western and Eastern countries. World J Gastroenterol 2015; 21(26): 7933-7943 [PMID: 26185366 DOI: 10.3748/wjg.v21.i26.7933] [Cited by in CrossRef: 363] [Cited by in F6Publishing: 342] [Article Influence: 51.9] [Reference Citation Analysis]
Number Citing Articles
1 Shi M, Tang J, Cao Z. Nomograms for predicting survival in early-onset esophageal cancer. Expert Review of Gastroenterology & Hepatology 2021;15:437-46. [DOI: 10.1080/17474124.2021.1842194] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Cheng L, Shi G, Fang C, Li G, Zheng Y, Chen W. Identifying the differentially expressed microRNAs in esophagus squamous cell carcinoma of Kazakh patients in Xinjiang. Oncol Lett 2019;17:2657-68. [PMID: 30854040 DOI: 10.3892/ol.2019.9904] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
3 Zhang X, Wang Y, Zhao L, Sang S, Zhang L. Prognostic value of platelet-to-lymphocyte ratio in oncologic outcomes of esophageal cancer: A systematic review and meta-analysis. Int J Biol Markers 2018;33:335-44. [DOI: 10.1177/1724600818766889] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
4 Zhao J, Lei T, Zhang T, Chen X, Dong J, Guan Y, Wang J, Wei H, Er P, Han D, Wei X, Guo Z, Du Q, Wang J, Liu N, Song Y, Yuan Z, Zhao L, Zhang W, Pang Q, Wang P. The efficacy and safety of simultaneous integrated dose reduction in clinical target volume with intensity-modulated radiotherapy for patients with locally advanced esophageal squamous cell carcinoma. Ann Transl Med 2020;8:1160. [PMID: 33241009 DOI: 10.21037/atm-20-4366] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Li Z, Li S, Wen Y, Chen J, Liu K, Jia J. MiR-495 Inhibits Cisplatin Resistance and Angiogenesis in Esophageal Cancer by Targeting ATP7A. Technol Cancer Res Treat 2021;20:15330338211039127. [PMID: 34747666 DOI: 10.1177/15330338211039127] [Reference Citation Analysis]
6 Wei L, Wang B, Hu L, Xu Y, Li Z, Shen Y, Huang H. MEX3A is upregulated in esophageal squamous cell carcinoma (ESCC) and promotes development and progression of ESCC through targeting CDK6. Aging (Albany NY) 2020;12:21091-113. [PMID: 33188661 DOI: 10.18632/aging.103196] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
7 Yao F, Yu J, He Y, Liu J, Li H, Liu Q, Long H, Wu Q. Primary impact of Gli1 on radioresistance in esophageal cancer. Oncol Lett 2019;18:4825-33. [PMID: 31611993 DOI: 10.3892/ol.2019.10837] [Reference Citation Analysis]
8 Wang L, Wang L, Chang W, Li Y, Wang L. MicroRNA-373 promotes the development of esophageal squamous cell carcinoma by targeting LATS2 and OXR1. Int J Biol Markers 2019;34:148-55. [PMID: 30852977 DOI: 10.1177/1724600819827964] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
9 He S, Zhang H, Xiao Z, Bhushan S, Gao K, Wang W. The interaction of TEA domain transcription factor 4 (TEAD4) and Yes-associated protein 1 (YAP1) promoted the malignant process mediated by serum/glucocorticoid regulated kinase 1 (SGK1). Bioengineered 2021;12:601-14. [PMID: 33517828 DOI: 10.1080/21655979.2021.1882142] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Soares-Lima SC, Mehanna H, Camuzi D, de Souza-Santos PT, Simão TA, Nicolau-Neto P, Almeida Lopes MS, Cuenin C, Talukdar FR, Batis N, Costa I, Dias F, Degli Esposti D, Boroni M, Herceg Z, Ribeiro Pinto LF. Upper Aerodigestive Tract Squamous Cell Carcinomas Show Distinct Overall DNA Methylation Profiles and Different Molecular Mechanisms behind WNT Signaling Disruption. Cancers (Basel) 2021;13:3014. [PMID: 34208581 DOI: 10.3390/cancers13123014] [Reference Citation Analysis]
11 Hao J, Li S, Li J, Jiang Z, Ghaffar M, Wang M, Jia R, Chen S, Wang Y, Zeng Y. Investigation into the expression levels of MAGEA6 in esophageal squamous cell carcinoma and esophageal adenocarcinoma tissues. Exp Ther Med 2019;18:1816-22. [PMID: 31410142 DOI: 10.3892/etm.2019.7735] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
12 Sieri S, Krogh V. Dietary glycemic index, glycemic load and cancer: An overview of the literature. Nutrition, Metabolism and Cardiovascular Diseases 2017;27:18-31. [DOI: 10.1016/j.numecd.2016.09.014] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
13 Hou N, Ma J, Li W, Zhao L, Gao Q, Mai L. T-cell immunoglobulin and mucin domain-containing protein-3 and galectin-9 protein expression: Potential prognostic significance in esophageal squamous cell carcinoma for Chinese patients. Oncol Lett 2017;14:8007-13. [PMID: 29344243 DOI: 10.3892/ol.2017.7188] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
14 Feng Z, Li X, Qiu M, Luo R, Lin J, Liu B. LncRNA EGFR-AS1 Upregulates ROCK1 by Sponging miR-145 to Promote Esophageal Squamous Cell Carcinoma Cell Invasion and Migration. Cancer Biother Radiopharm 2020;35:66-71. [PMID: 31702393 DOI: 10.1089/cbr.2019.2926] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
15 El‐zimaity H, Di Pilato V, Novella Ringressi M, Brcic I, Rajendra S, Langer R, Dislich B, Tripathi M, Guindi M, Riddell R. Risk factors for esophageal cancer: emphasis on infectious agents. Ann N Y Acad Sci 2018;1434:319-32. [DOI: 10.1111/nyas.13858] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
16 Pu Y, Jin P, Liu L, Pu Q, Wu F. Dysosma versipellis Extract Inhibits Esophageal Cancer Progression through the Wnt Signaling Pathway. Evid Based Complement Alternat Med 2021;2021:1221899. [PMID: 34729077 DOI: 10.1155/2021/1221899] [Reference Citation Analysis]
17 Gerayllo S, Morowatisharifabad MA, Jouybari L, Amirbeigy MK, Fallahzadeh H. Prevention behaviours of oesophageal cancer: Protocol for a mixed-method study. J Adv Nurs 2019;75:3768-73. [PMID: 31441532 DOI: 10.1111/jan.14178] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
18 Sang Y, Gu H, Chen Y, Shi Y, Liu C, Lv L, Sun Y, Zhang Y. Long non-coding RNA CASC8 polymorphisms are associated with the risk of esophageal cancer in a Chinese population. Thorac Cancer 2020;11:2852-7. [PMID: 32875717 DOI: 10.1111/1759-7714.13612] [Reference Citation Analysis]
19 Kim JH, Han KD, Lee JK, Kim HS, Cha JM, Park S, Kim JS, Kim WH; Big Data Research Group (BDRG) of the Korean Society of Gastroenterology (KSG). Association between the National Cancer Screening Programme (NSCP) for gastric cancer and oesophageal cancer mortality. Br J Cancer 2020;123:480-6. [PMID: 32398860 DOI: 10.1038/s41416-020-0883-x] [Reference Citation Analysis]
20 Kwak AW, Lee MH, Yoon G, Cho SS, Choi JS, Chae JI, Shim JH. Deoxypodophyllotoxin, a Lignan from Anthriscus sylvestris, Induces Apoptosis and Cell Cycle Arrest by Inhibiting the EGFR Signaling Pathways in Esophageal Squamous Cell Carcinoma Cells. Int J Mol Sci 2020;21:E6854. [PMID: 32961992 DOI: 10.3390/ijms21186854] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Pattamatta M, Fransen LFC, Dolmans-Zwartjes ACP, Nieuwenhuijzen GAP, Evers SMAA, Kouwenhoven EA, van Det MJ, Hiligsmann M, Luyer MDP. Effect of direct oral feeding following minimally invasive esophagectomy on costs and quality of life. J Med Econ 2021;24:54-60. [PMID: 33274674 DOI: 10.1080/13696998.2020.1859843] [Reference Citation Analysis]
22 Yang W, Han Y, Zhao X, Duan L, Zhou W, Wang X, Shi G, Che Y, Zhang Y, Liu J, Zhang H, Zhao Q, Hong L, Fan D. Advances in prognostic biomarkers for esophageal cancer. Expert Review of Molecular Diagnostics 2019;19:109-19. [DOI: 10.1080/14737159.2019.1563485] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
23 Wang L, Ji XB, Wang LH, Xia ZK, Xie YX, Liu WJ, Qiu JG, Jiang BH, Liu LZ. MiRNA-30e downregulation increases cancer cell proliferation, invasion and tumor growth through targeting RPS6KB1. Aging (Albany NY) 2021;13:24037-49. [PMID: 34727092 DOI: 10.18632/aging.203665] [Reference Citation Analysis]
24 Yang C, Zheng S, Liu T, Liu Q, Dai F, Zhou J, Chen Y, Sheyhidin I, Lu X. Down-regulated miR-26a promotes proliferation, migration, and invasion via negative regulation of MTDH in esophageal squamous cell carcinoma. FASEB J 2017;31:2114-22. [PMID: 28174206 DOI: 10.1096/fj.201601237] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
25 Guo L, Zhang L, Zhao J. CT scan and magnetic resonance diffusion-weighted imaging in the diagnosis and treatment of esophageal cancer. Oncol Lett 2018;16:7117-22. [PMID: 30546446 DOI: 10.3892/ol.2018.9532] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
26 Qiu F, Liu L, Lin Y, Yang Z, Qiu F. Corilagin Inhibits Esophageal Squamous Cell Carcinoma by Inducing DNA Damage and Down-Regulation of RNF8. Anticancer Agents Med Chem 2019;19:1021-8. [PMID: 30848215 DOI: 10.2174/1871520619666190307120811] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
27 Lin L, Li Z, Yan L, Liu Y, Yang H, Li H. Global, regional, and national cancer incidence and death for 29 cancer groups in 2019 and trends analysis of the global cancer burden, 1990-2019. J Hematol Oncol 2021;14:197. [PMID: 34809683 DOI: 10.1186/s13045-021-01213-z] [Reference Citation Analysis]
28 Guo XF, Li SS, Zhu XF, Dou QH, Liu D. Lapatinib in combination with paclitaxel plays synergistic antitumor effects on esophageal squamous cancer. Cancer Chemother Pharmacol 2018;82:383-94. [PMID: 29909520 DOI: 10.1007/s00280-018-3627-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
29 Yang H, Wang JB, Zhang JY, Fan JH, Qiao YL, Taylor PR. Family History and Risk of Upper Gastrointestinal Cancer in the Linxian General Population. Front Oncol 2021;11:605106. [PMID: 34123779 DOI: 10.3389/fonc.2021.605106] [Reference Citation Analysis]
30 Wang Y, Chen L, Wu Y, Li P, Che G. The prognostic value of modified Glasgow prognostic score in patients with esophageal squamous cell cancer: a Meta-analysis. Nutr Cancer 2020;72:1146-54. [PMID: 31617767 DOI: 10.1080/01635581.2019.1677925] [Cited by in Crossref: 4] [Article Influence: 1.3] [Reference Citation Analysis]
31 Zheng C, Wang J, Xie S. P2RX7 Gene rs1718125 Polymorphism is Related with Postoperative Pain and Fentanyl Intake in Esophageal Cancer Patients. Pharmgenomics Pers Med 2020;13:585-9. [PMID: 33209050 DOI: 10.2147/PGPM.S252798] [Reference Citation Analysis]
32 Lu Y, Wang Z, Zhou L, Ma Z, Zhang J, Wu Y, Shao Y, Yang Y. FAT1 and PTPN14 Regulate the Malignant Progression and Chemotherapy Resistance of Esophageal Cancer through the Hippo Signaling Pathway. Anal Cell Pathol (Amst) 2021;2021:9290372. [PMID: 34712552 DOI: 10.1155/2021/9290372] [Reference Citation Analysis]
33 Wu CW, Chuang HY, Tsai DL, Kuo TY, Yang CC, Chen HC, Kuo CH. Meta-Analysis of the Association between Asbestos Exposure and Esophageal Cancer. Int J Environ Res Public Health 2021;18:11088. [PMID: 34769609 DOI: 10.3390/ijerph182111088] [Reference Citation Analysis]
34 Feng JF, Wang L, Jiang YH, Yang X. C-Reactive Protein to Prealbumin Ratio (CPR): A Novel Inflammatory-Nutritional Prognostic Factor for Predicting Cancer-Specific Survival (CSS) and Overall Survival (OS) in Patients with Resectable Esophageal Squamous Cell Carcinoma. J Oncol 2019;2019:4359103. [PMID: 31379941 DOI: 10.1155/2019/4359103] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
35 Liu M, Liu Z, Liu F, Guo C, Xu R, Li F, Liu A, Yang H, Zhang S, Shen L, Duan L, Wu Q, Cao C, Pan Y, Liu Y, Li J, Cai H, He Z, Ke Y. Absence of Iodine Staining Associates With Progression of Esophageal Lesions in a Prospective Endoscopic Surveillance Study in China. Clin Gastroenterol Hepatol. 2019;. [PMID: 31518715 DOI: 10.1016/j.cgh.2019.08.058] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
36 Zhang H, Zhong J, Tu Y, Liu B, Chen Z, Luo Y, Tang Y, Xiao F. Integrated Bioinformatics Analysis Identifies Hub Genes Associated with the Pathogenesis and Prognosis of Esophageal Squamous Cell Carcinoma. Biomed Res Int. 2019;2019:2615921. [PMID: 31950035 DOI: 10.1155/2019/2615921] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
37 Pan J, Zang Y. LINC00667 Promotes Progression of Esophageal Cancer Cells by Regulating miR-200b-3p/SLC2A3 Axis. Dig Dis Sci 2021. [PMID: 34313922 DOI: 10.1007/s10620-021-07145-5] [Reference Citation Analysis]
38 Zhang Y, Xiao G, Wang R. Clinical significance of systemic immune-inflammation index (SII) and C-reactive protein-to-albumin ratio (CAR) in patients with esophageal cancer: a meta-analysis. Cancer Manag Res 2019;11:4185-200. [PMID: 31190988 DOI: 10.2147/CMAR.S190006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
39 Lei J, Han Q, Zhu S, Shi D, Dou S, Su Z, Xu X. Assessment of esophageal carcinoma undergoing concurrent chemoradiotherapy with quantitative dynamic contrast-enhanced magnetic resonance imaging. Oncol Lett. 2015;10:3607-3612. [PMID: 26788177 DOI: 10.3892/ol.2015.3779] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
40 Kanda M, Koike M, Tanaka C, Kobayashi D, Hattori N, Hayashi M, Yamada S, Omae K, Fujiwara M, Kodera Y. Modified Systemic Inflammation Score is Useful for Risk Stratification After Radical Resection of Squamous Cell Carcinoma of the Esophagus. Ann Surg Oncol 2019;26:4773-81. [PMID: 31605344 DOI: 10.1245/s10434-019-07914-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
41 Xu Z, Wu Z, Zhang J, Zhou R, Wu J, Yu B. Development of Multiscale Transcriptional Regulatory Network in Esophageal Cancer Based on Integrated Analysis. Biomed Res Int 2020;2020:5603958. [PMID: 32851080 DOI: 10.1155/2020/5603958] [Reference Citation Analysis]
42 Luo M, Yang Y, Luo D, Liu L, Zhang Y, Xiao F, Yang J, Zhang C, Fu S, Luo Z. Tumor necrosis factor-alpha promoter polymorphism 308 G/A is not significantly associated with esophageal cancer risk: a meta-analysis. Oncotarget 2016;7:79901-13. [PMID: 27821804 DOI: 10.18632/oncotarget.13093] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
43 Li N, Zhao Z, Miao F, Cai S, Liu P, Yu Y, Wang B. Silencing of long non-coding RNA LINC01270 inhibits esophageal cancer progression and enhances chemosensitivity to 5-fluorouracil by mediating GSTP1methylation. Cancer Gene Ther 2021;28:471-85. [PMID: 33199829 DOI: 10.1038/s41417-020-00232-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
44 Syed T, Doshi A, Guleria S, Syed S, Shah T. Artificial Intelligence and Its Role in Identifying Esophageal Neoplasia. Dig Dis Sci 2020;65:3448-55. [PMID: 33057945 DOI: 10.1007/s10620-020-06643-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
45 Li Y, Yangjin C, Shi Y, Wen Y, Jin Z, Cui R, Zhang H, Ding S. The Significance of a Pale Area Via Flexible Spectral Imaging Color Enhancement in the Diagnosis of Esophageal Precancerous Lesions and Early-stage Squamous Cancer. J Clin Gastroenterol 2019;53:e400-4. [PMID: 30829906 DOI: 10.1097/MCG.0000000000001191] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
46 Guan L, Zou Q, Liu Q, Lin Y, Chen S. HSP90 Inhibitor Ganetespib (STA-9090) Inhibits Tumor Growth in c-Myc-Dependent Esophageal Squamous Cell Carcinoma. Onco Targets Ther 2020;13:2997-3011. [PMID: 32308431 DOI: 10.2147/OTT.S245813] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
47 Arantes V, Espinoza-Ríos J. Early esophageal squamous cell carcinoma management through endoscopic submucosal dissection. Rev Gastroenterol Mex (Engl Ed) 2018;83:259-67. [PMID: 29551245 DOI: 10.1016/j.rgmx.2017.12.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
48 Wu XX, Chen RP, Chen RC, Gong HP, Wang BF, Li YL, Lin XR, Huang ZM. Nomogram predicting cancer-specific mortality in patients with esophageal adenocarcinoma: a competing risk analysis. J Thorac Dis 2019;11:2990-3003. [PMID: 31463129 DOI: 10.21037/jtd.2019.07.56] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
49 Song L, Wang Y, Weng G. Metastasis in penile corpus cavernosum from esophageal squamous carcinoma after curative resection: a case report. BMC Cancer 2019;19:162. [PMID: 30786867 DOI: 10.1186/s12885-019-5356-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
50 Habbous S, Yermakhanova O, Forster K, Holloway CMB, Darling G. Variation in Diagnosis, Treatment, and Outcome of Esophageal Cancer in a Regionalized Care System in Ontario, Canada. JAMA Netw Open 2021;4:e2126090. [PMID: 34546371 DOI: 10.1001/jamanetworkopen.2021.26090] [Reference Citation Analysis]
51 Nesteruk K, Janmaat VT, Liu H, Ten Hagen TLM, Peppelenbosch MP, Fuhler GM. Forced expression of HOXA13 confers oncogenic hallmarks to esophageal keratinocytes. Biochim Biophys Acta Mol Basis Dis 2020;1866:165776. [PMID: 32222541 DOI: 10.1016/j.bbadis.2020.165776] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
52 Guo JC, Xie YM, Ran LQ, Cao HH, Sun C, Wu JY, Wu ZY, Liao LD, Zhao WJ, Fang WK, Li EM, Xu LY, Schachner M, Xie JJ. L1CAM drives oncogenicity in esophageal squamous cell carcinoma by stimulation of ezrin transcription. J Mol Med (Berl) 2017;95:1355-68. [PMID: 28939985 DOI: 10.1007/s00109-017-1595-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
53 Zhang CY, Zhang J, Ma YF, Zhe H, Zhao R, Wang YY. Prognostic Value of Combined Analysis of CTLA-4 and PLR in Esophageal Squamous Cell Carcinoma (ESCC) Patients. Dis Markers 2019;2019:1601072. [PMID: 31485274 DOI: 10.1155/2019/1601072] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
54 Schulpen M, Peeters PH, van den Brandt PA. Mediterranean diet adherence and risk of esophageal and gastric cancer subtypes in the Netherlands Cohort Study. Gastric Cancer 2019;22:663-74. [PMID: 30771119 DOI: 10.1007/s10120-019-00927-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
55 Zheng D, Wan C, Yang H, Xu L, Dong Q, Du C, Du J, Li F. Her2-Targeted Multifunctional Nano-Theranostic Platform Mediates Tumor Microenvironment Remodeling and Immune Activation for Breast Cancer Treatment. Int J Nanomedicine 2020;15:10007-28. [PMID: 33376321 DOI: 10.2147/IJN.S271213] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
56 Amorim CA, De Souza LP, Moreira JP, Luiz RR, De V Carneiro AJ, De Souza HSP. Geographic distribution and time trends of esophageal cancer in Brazil from 2005 to 2015. Mol Clin Oncol 2019;10:631-8. [PMID: 31086670 DOI: 10.3892/mco.2019.1842] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
57 Jesinghaus M, Boxberg M, Konukiewitz B, Slotta-Huspenina J, Schlitter AM, Steiger K, Specht K, Wieczorek K, Warth A, Schmidt T, Hartmann A, Demir IE, Feith M, Ott K, Weichert W. A Novel Grading System Based on Tumor Budding and Cell Nest Size Is a Strong Predictor of Patient Outcome in Esophageal Squamous Cell Carcinoma. Am J Surg Pathol 2017;41:1112-20. [PMID: 28505009 DOI: 10.1097/PAS.0000000000000865] [Cited by in Crossref: 25] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
58 Huang Z, Zhou B, Li Z, Liu C, Zheng C, Zeng R, Hong C, Xu L, Li E, Peng Y, Xu Y. Serum interleukin-8 as a potential diagnostic biomarker in esophageal squamous cell carcinoma. Cancer Biomark 2020;29:139-49. [PMID: 32623391 DOI: 10.3233/CBM-201687] [Reference Citation Analysis]
59 Xu J, Wang G, Gong W, Guo S, Li D, Zhan Q. The noncoding function of NELFA mRNA promotes the development of oesophageal squamous cell carcinoma by regulating the Rad17-RFC2-5 complex. Mol Oncol 2020;14:611-24. [PMID: 31845510 DOI: 10.1002/1878-0261.12619] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
60 Zhou Y, Wang Q, Chu L, Dai W, Zhang X, Chen J, Zhang L, Ding P, Zhang X, Gu H, Zhang P, Li L, Zhang W, Li L, Lv X, Zhou D, Cai G, Chen L, Zhao K, Hu W. FOXM1c promotes oesophageal cancer metastasis by transcriptionally regulating IRF1 expression. Cell Prolif 2019;52:e12553. [PMID: 30485581 DOI: 10.1111/cpr.12553] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
61 Yuan W, Yan J, Liu H, Li L, Wu B, Guo C, Zhang M. Identification of Prognostic Related Genes of Tumor Microenvironment Derived From Esophageal Cancer Patients. Pathol Oncol Res 2021;27:589662. [PMID: 34257539 DOI: 10.3389/pore.2021.589662] [Reference Citation Analysis]
62 Hartmans E, Linssen MD, Sikkens C, Levens A, Witjes MJH, van Dam GM, Nagengast WB. Tyrosine kinase inhibitor induced growth factor receptor upregulation enhances the efficacy of near-infrared targeted photodynamic therapy in esophageal adenocarcinoma cell lines. Oncotarget 2017;8:29846-56. [PMID: 28415738 DOI: 10.18632/oncotarget.16165] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
63 Liu D, Wu K, Yang Y, Zhu D, Zhang C, Zhao S. Long noncoding RNA ADAMTS9-AS2 suppresses the progression of esophageal cancer by mediating CDH3 promoter methylation. Mol Carcinog 2020;59:32-44. [PMID: 31621118 DOI: 10.1002/mc.23126] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
64 Chen W, Zhang Y, Wang H, Pan T, Zhang Y, Li C. LINC00473/miR-374a-5p regulates esophageal squamous cell carcinoma via targeting SPIN1 to weaken the effect of radiotherapy. J Cell Biochem 2019;120:14562-72. [PMID: 31017716 DOI: 10.1002/jcb.28717] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
65 Gao J, Xia R, Chen J, Gao J, Luo X, Ke C, Ren C, Li J, Mi Y. Inhibition of esophageal-carcinoma cell proliferation by genistein via suppression of JAK1/2-STAT3 and AKT/MDM2/p53 signaling pathways. Aging (Albany NY) 2020;12:6240-59. [PMID: 32276266 DOI: 10.18632/aging.103019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
66 Li J, Zeng Z, Jiang X, Zhang N, Gao Y, Luo Y, Sun W, Li S, Ren J, Gong Y, Xie C. Stromal microenvironment promoted infiltration in esophageal adenocarcinoma and squamous cell carcinoma: a multi-cohort gene-based analysis. Sci Rep 2020;10:18589. [PMID: 33122682 DOI: 10.1038/s41598-020-75541-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
67 Liu GM, Ji X, Lu TC, Duan LW, Jia WY, Liu Y, Sun ML, Luo YG. Comprehensive multi-omics analysis identified core molecular processes in esophageal cancer and revealed GNGT2 as a potential prognostic marker. World J Gastroenterol 2019; 25(48): 6890-6901 [PMID: 31908393 DOI: 10.3748/wjg.v25.i48.6890] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
68 Yang B, Ma H, Bian Y. LINC00261 Inhibits Esophageal Cancer Radioresistance by Down-Regulating microRNA-552-3p and Promoting DIRAS1. Cancer Manag Res 2021;13:8559-73. [PMID: 34803403 DOI: 10.2147/CMAR.S332640] [Reference Citation Analysis]
69 Zhou C, Zhong X, Gao P, Wu Z, Shi J, Guo Z, Wang Z, Song Y. Statin use and its potential therapeutic role in esophageal cancer: a systematic review and meta-analysis. Cancer Manag Res 2019;11:5655-63. [PMID: 31417309 DOI: 10.2147/CMAR.S193945] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
70 Ji A, Jin R, Zhang R, Li H. Primary small cell carcinoma of the esophagus: progression in the last decade. Ann Transl Med 2020;8:502. [PMID: 32395546 DOI: 10.21037/atm.2020.03.214] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
71 Wang J, Luo FF, Huang TJ, Mei Y, Peng LX, Qian CN, Huang BJ. The upregulated expression of RFC4 and GMPS mediated by DNA copy number alteration is associated with the early diagnosis and immune escape of ESCC based on a bioinformatic analysis. Aging (Albany NY) 2021;13:21758-77. [PMID: 34520390 DOI: 10.18632/aging.203520] [Reference Citation Analysis]
72 Zhang JH, Xia HB. Lentiviral-Mediated Overexpression of MicroRNA-141 Promotes Cell Proliferation and Inhibits Apoptosis in Human Esophageal Squamous Cell Carcinoma. Recent Pat Anticancer Drug Discov 2019;14:170-6. [PMID: 30599110 DOI: 10.2174/1574892814666181231142136] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
73 Sudo T, Kawahara A, Ishi K, Mizoguchi A, Nagasu S, Nakagawa M, Fujisaki M, Hino H, Saisho K, Kaku H, Matono S, Mori N, Akiba J, Yamada A, Akagi Y. Diversity and shared T-cell receptor repertoire analysis in esophageal squamous cell carcinoma. Oncol Lett 2021;22:618. [PMID: 34257726 DOI: 10.3892/ol.2021.12879] [Reference Citation Analysis]
74 Raghu Subramanian C, Triadafilopoulos G. Diagnosis and therapy of esophageal squamous cell dysplasia and early esophageal squamous cell cancer. Gastroenterology Report 2017;5:247-57. [DOI: 10.1093/gastro/gox022] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
75 Yuan C, Xiang L, Cao K, Zhang J, Luo Y, Sun W, Zhang N, Ren J, Zhang J, Gong Y, Xie C. The prognostic value of tumor mutational burden and immune cell infiltration in esophageal cancer patients with or without radiotherapy. Aging (Albany NY). 2020;12:4603-4616. [PMID: 32165590 DOI: 10.18632/aging.102917] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
76 Öksüz E, Görgişen G, Oto G, Özdemir H, Aras A, Öksüz M, Gülaçar İM, Demirkol MH. Relationship between MTHFR Gene Polymorphisms and Gastrointestinal Tumors Development: Perspective from Eastern Part of Turkey. J Invest Surg 2020;:1-9. [PMID: 33322951 DOI: 10.1080/08941939.2020.1824249] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
77 Bian W, Li Y, Zhu H, Gao S, Niu R, Wang C, Zhang H, Qin X, Li S. miR-493 by regulating of c-Jun targets Wnt5a/PD-L1-inducing esophageal cancer cell development. Thorac Cancer 2021;12:1579-88. [PMID: 33793074 DOI: 10.1111/1759-7714.13950] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
78 Genco A, Castagneto-Gissey L, Lorenzo M, Ernesti I, Soricelli E, Casella G. Esophageal adenocarcinoma after sleeve gastrectomy: actual or potential threat? Italian series and literature review. Surg Obes Relat Dis 2021;17:848-54. [PMID: 33380354 DOI: 10.1016/j.soard.2020.11.023] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
79 Chen Y, Zhou H, Wang Z, Huang Z, Wang J, Zheng M, Ni X, Liu L. Integrated analysis of ceRNA network and tumor-infiltrating immune cells in esophageal cancer. Biosci Rep 2021;41:BSR20203804. [PMID: 33960364 DOI: 10.1042/BSR20203804] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
80 Du L, Fei Z, Song S, Wei N. Antitumor activity of Lobaplatin against esophageal squamous cell carcinoma through caspase-dependent apoptosis and increasing the Bax/Bcl-2 ratio. Biomedicine & Pharmacotherapy 2017;95:447-52. [DOI: 10.1016/j.biopha.2017.08.119] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 4.4] [Reference Citation Analysis]
81 Zhu J, Ma S, Zhou Y, Chen R, Xie S, Liu Z, Li X, Wei W. The association between depression and esophageal cancer in China: a multicentre population-based study. BMC Psychiatry 2021;21:554. [PMID: 34758767 DOI: 10.1186/s12888-021-03534-2] [Reference Citation Analysis]
82 Abbas H, Ghazanfar H, Ul Hussain AN, Baiomi A, Ihimoyan A. Atypical Presentation of Esophageal Squamous Cell Carcinoma Masquerading as Diffuse Severe Esophagitis. Case Rep Gastroenterol 2021;15:533-8. [PMID: 34616252 DOI: 10.1159/000517129] [Reference Citation Analysis]
83 Wakefield CJ, Hamati F, Karush JM, Arndt AT, Geissen N, Liptay MJ, Borgia JA, Basu S, Seder CW. Sarcopenia after induction therapy is associated with reduced survival in patients undergoing esophagectomy for locally-advanced esophageal cancer. J Thorac Dis 2021;13:861-9. [PMID: 33717559 DOI: 10.21037/jtd-20-2608] [Reference Citation Analysis]
84 Wu K, Zhang C, Zhang C, Dai D. A Novel Three-miRNA Signature Identified Using Bioinformatics Predicts Survival in Esophageal Carcinoma. Biomed Res Int 2020;2020:5973082. [PMID: 32104700 DOI: 10.1155/2020/5973082] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
85 Guo Z, Yan X, Song C, Wang Q, Wang Y, Liu XP, Huang J, Li S, Hu W. FAT3 Mutation Is Associated With Tumor Mutation Burden and Poor Prognosis in Esophageal Cancer. Front Oncol 2021;11:603660. [PMID: 33816234 DOI: 10.3389/fonc.2021.603660] [Reference Citation Analysis]
86 Ding CZ, Wang GL, Wang HT, Wang WG, Wang L, Wang PF, Zhu RJ, Liu X, Wang JH, Wang J, Zhao S. Esophagectomy combined with off-pump coronary artery bypass grafting through left posterolateral incision is safe and feasible for esophageal cancer associated with coronary artery disease. Dis Esophagus 2021:doaa123. [PMID: 33442734 DOI: 10.1093/dote/doaa123] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
87 Zhang N, Zhang SW. Long-term effects of radiation prior to surgery and chemotherapy on survival of esophageal cancer undergoing surgery. Medicine (Baltimore) 2019;98:e17617. [PMID: 31651875 DOI: 10.1097/MD.0000000000017617] [Reference Citation Analysis]
88 Bai M, Dong Y, Zhou C, Sun X, Ma J, Han S. Effect of miR-196a inhibition on esophageal cancer growth in vitro. Anticancer Drugs 2020;31:169-76. [PMID: 31743132 DOI: 10.1097/CAD.0000000000000823] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
89 Miwa T, Kanda M, Koike M, Iwata N, Tanaka H, Umeda S, Tanaka C, Kobayashi D, Hayashi M, Yamada S, Fujii T, Fujiwara M, Kodera Y. Identification of NCCRP1 as an epigenetically regulated tumor suppressor and biomarker for malignant phenotypes of squamous cell carcinoma of the esophagus. Oncol Lett 2017;14:4822-8. [PMID: 29085486 DOI: 10.3892/ol.2017.6753] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
90 Popescu GDA, Scheau C, Badarau IA, Dumitrache MD, Caruntu A, Scheau AE, Costache DO, Costache RS, Constantin C, Neagu M, Caruntu C. The Effects of Capsaicin on Gastrointestinal Cancers. Molecules 2020;26:E94. [PMID: 33379302 DOI: 10.3390/molecules26010094] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
91 Chen S, Shen Z, Liu Z, Gao L, Han Z, Yu S, Kang M. IL-1RA suppresses esophageal cancer cell growth by blocking IL-1α. J Clin Lab Anal 2019;33:e22903. [PMID: 31102307 DOI: 10.1002/jcla.22903] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
92 Wang F, Wang Y, Chen Z, Chen J, Qin F, Jiang W, Li Y. A phase IIa study of rhLTα-Da in combination with cisplatin and fluorouracil for patients with metastatic esophageal squamous cell carcinoma or gastric adenocarcinoma. Med Oncol 2016;33. [DOI: 10.1007/s12032-016-0846-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
93 Yang Y, Zhou X, Tang L, Xu X, Du X, Qiu G. Role of Perioperative Chemotherapy in Lymph Node-negative Esophageal Cancer After Resection: A Population-based Study With Propensity Score-matched Analysis. Am J Clin Oncol 2019;42:924-31. [PMID: 31651453 DOI: 10.1097/COC.0000000000000624] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
94 Hwang J, Haque MA, Suzuki H, Dijke PT, Kato M. THG-1 suppresses SALL4 degradation to induce stemness genes and tumorsphere formation through antagonizing NRBP1 in squamous cell carcinoma cells. Biochem Biophys Res Commun 2020;523:307-14. [PMID: 31864704 DOI: 10.1016/j.bbrc.2019.11.149] [Reference Citation Analysis]
95 Marguet S, Adenis A, Delaine-Clisant S, Penel N, Bonastre J. Cost-Utility Analysis of Continuation Versus Discontinuation of First-Line Chemotherapy in Patients With Metastatic Squamous-Cell Esophageal Cancer: Economic Evaluation Alongside the E-DIS Trial. Value Health 2021;24:676-82. [PMID: 33933236 DOI: 10.1016/j.jval.2020.11.017] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
96 Wang J, Wang Q, Gong Y, Hu Q, Zhang H, Ke S, Chen Y. Knockdown of circRNA circ_0087378 Represses the Tumorigenesis and Progression of Esophageal Squamous Cell Carcinoma Through Modulating the miR-140-3p/E2F3 Axis. Front Oncol 2020;10:607231. [PMID: 33680929 DOI: 10.3389/fonc.2020.607231] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
97 Jia A, Wu Y, Ren W, Han P, Shao Y. Genetic variations of CARMN affect risk of esophageal cancer in northwest China. Gene 2020;748:144680. [DOI: 10.1016/j.gene.2020.144680] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
98 Feng JF, Sheng C, Zhao Q, Chen P. Prognostic value of mean platelet volume/platelet count ratio in patients with resectable esophageal squamous cell carcinoma: a retrospective study. PeerJ 2019;7:e7246. [PMID: 31328033 DOI: 10.7717/peerj.7246] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
99 Deng J, Weng X, Ye J, Zhou D, Liu Y, Zhao K. Identification of the Germline Mutation Profile in Esophageal Squamous Cell Carcinoma by Whole Exome Sequencing. Front Genet 2019;10:47. [PMID: 30833958 DOI: 10.3389/fgene.2019.00047] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
100 Hao J, Chen C, Wan F, Zhu Y, Jin H, Zhou J, Chen N, Yang J, Pu Q. Prognostic Value of Pre-Treatment Prognostic Nutritional Index in Esophageal Cancer: A Systematic Review and Meta-Analysis. Front Oncol 2020;10:797. [PMID: 32626652 DOI: 10.3389/fonc.2020.00797] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
101 Gao Y, Zhu Y, Xu X, Wang F, Shen W, Leng X, Zhao J, Liu B, Wang Y, Liu P. Surface PEGylated Cancer Cell Membrane-Coated Nanoparticles for Codelivery of Curcumin and Doxorubicin for the Treatment of Multidrug Resistant Esophageal Carcinoma. Front Cell Dev Biol 2021;9:688070. [PMID: 34386493 DOI: 10.3389/fcell.2021.688070] [Reference Citation Analysis]
102 Wang D, Guo C, Kong T, Mi G, Li J, Sun Y. Serum miR-22 may be a biomarker for papillary thyroid cancer. Oncol Lett 2019;17:3355-61. [PMID: 30867770 DOI: 10.3892/ol.2019.10011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
103 Ma L, Zhao X, Wang S, Zheng Y, Yang S, Hou Y, Zou B, Dong L. Decreased expression of DEAD-Box helicase 5 inhibits esophageal squamous cell carcinomas by regulating endoplasmic reticulum stress and autophagy. Biochem Biophys Res Commun 2020;533:1449-56. [PMID: 33169694 DOI: 10.1016/j.bbrc.2020.10.026] [Reference Citation Analysis]
104 Yao YW, He YF, Han XH, Ji CS, Hu B. Clinical research of individualized therapy in advanced esophageal cancer based on the ERCC1 C8092A genotype. Oncol Lett 2018;16:2539-48. [PMID: 30013648 DOI: 10.3892/ol.2018.8894] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
105 Chen D, Wang W, Chen Y, Hu J, Yang M, Mo J, Wen Z. Recurrence and prognostic model for identifying patients at risk for esophageal cancer after surgery. Cancer Manag Res 2018;10:6109-20. [PMID: 30538559 DOI: 10.2147/CMAR.S186194] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
106 Thin KZ, Tu JC, Raveendran S. Long non-coding SNHG1 in cancer. Clin Chim Acta 2019;494:38-47. [PMID: 30849309 DOI: 10.1016/j.cca.2019.03.002] [Cited by in Crossref: 36] [Cited by in F6Publishing: 42] [Article Influence: 12.0] [Reference Citation Analysis]
107 Yao L, Yu F, Mao Y, Wang T, Qi Q, Ding H, Wang J, Ma H, Dai J, Zhang G, Jin G. Gastric cancer may share genetic predisposition with esophageal squamous cell carcinoma in Chinese populations. J Hum Genet 2018;63:1159-68. [DOI: 10.1038/s10038-018-0501-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
108 Lan T, Xue X, Dunmall LC, Miao J, Wang Y. Patient-derived xenograft: a developing tool for screening biomarkers and potential therapeutic targets for human esophageal cancers. Aging (Albany NY) 2021;13:12273-93. [PMID: 33903283 DOI: 10.18632/aging.202934] [Reference Citation Analysis]
109 Hamrah MH, Hamrah MSh, Kanda M, Sakamoto J, Hamrah MH, Hami A, Hamrah AE, Dahi AE, Hamrah MH. Esophageal Cancer and associated Factors among Uzbek-Turkmen and Other Ethnic Groups in the Northern Part of Afghanistan. Asian Pac J Cancer Prev 2017;18:333-7. [PMID: 28345328 DOI: 10.22034/APJCP.2017.18.2.333] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
110 Sharma M, Radhakrishnan R. Revisiting and revising the definition of oral submucous fibrosis. Oral Oncol 2019;92:94. [PMID: 30853277 DOI: 10.1016/j.oraloncology.2019.03.004] [Reference Citation Analysis]
111 Chan MQ, Balasubramanian G, Modi RM, Papachristou GI, Strobel SG, Groce JR, Hinton A, Krishna SG. Changing epidemiology of esophageal stent placement for dysphagia: a decade of trends and the impact of benign indications. Gastrointest Endosc 2020;92:56-64.e7. [PMID: 32105711 DOI: 10.1016/j.gie.2020.02.018] [Reference Citation Analysis]
112 Zhang T, Pan D, Su M, Fu L, Miao C, Yan Q, Wang J, Yang L, Wang S, Sun G. Determination of dietary nitrite in patients with esophageal pre-cancerous lesion and normal people: a duplicate diet study. Food Additives & Contaminants: Part A 2018;35:2298-308. [DOI: 10.1080/19440049.2018.1546906] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
113 Cao Y, Wang X, Tang L, Li Y, Song X, Liu X, Li M, Chen F, Wan H. Engrailed-2 promotes a malignant phenotype of esophageal squamous cell carcinoma through upregulating the expression of pro-oncogenic genes. PeerJ 2020;8:e8662. [PMID: 32117645 DOI: 10.7717/peerj.8662] [Reference Citation Analysis]
114 Colvin SD, Zarzour JG, Morgan DE, Callaway JP, Corey BL, Grams J, Galgano SJ. Same day barium esophagography and high-resolution manometry during the COVID-19 pandemic. Abdom Radiol (NY) 2021. [PMID: 34687322 DOI: 10.1007/s00261-021-03322-2] [Reference Citation Analysis]
115 Rastgar-Moghadam A, Mehramiz M, Shahidsales S, Entezari M, Hassanian SM, Talebian S, Nourbakhsh M, Ferns GA, Avan A. Association of a genetic variant in ATP-binding cassette sub-family B member 1 gene with poor prognosis in patients with squamous cell carcinoma of the esophagus. IUBMB Life 2019;71:1252-8. [PMID: 30865384 DOI: 10.1002/iub.2034] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
116 Zhao S, Qi W, Chen J. Competing risk nomogram to predict cancer-specific survival in esophageal cancer during the intensity-modulated radiation therapy era: A single institute analysis. Oncol Lett 2020;19:3513-21. [PMID: 32269625 DOI: 10.3892/ol.2020.11448] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
117 Gao H, Wang T, Zhang P, Shang M, Gao Z, Yang F, Liu R. Linc-ROR regulates apoptosis in esophageal squamous cell carcinoma via modulation of p53 ubiquitination by targeting miR-204-5p/MDM2. J Cell Physiol 2020;235:2325-35. [PMID: 31541467 DOI: 10.1002/jcp.29139] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
118 Du J. Upregulation of sine oculis homeobox homolog 3 is associated with proliferation, invasion, migration, as well as poor prognosis of esophageal cancer. Anticancer Drugs 2019;30:596-603. [PMID: 30672777 DOI: 10.1097/CAD.0000000000000751] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
119 Xie B, Lin J, Sui K, Huang Z, Chen Z, Hang W. Differential diagnosis of multielements in cancerous and non-cancerous esophageal tissues. Talanta 2019;196:585-91. [PMID: 30683409 DOI: 10.1016/j.talanta.2018.12.061] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
120 Zarean E, Amini P, Yaseri M, Hajihosseini M, Azimi T, Mahmoudi M. Determining Risk Factors for Gastric and Esophageal Cancers between 2009-2015 in East-Azarbayjan, Iran Using Parametric Survival Models. Asian Pac J Cancer Prev 2019;20:443-9. [PMID: 30803206 DOI: 10.31557/APJCP.2019.20.2.443] [Reference Citation Analysis]
121 Li B, Yu Y, Jiang Y, Zhao L, Li A, Li M, Yuan B, Lu J, Dong Z, Zhao J, Liu K. Cloperastine inhibits esophageal squamous cell carcinoma proliferation in vivo and in vitro by suppressing mitochondrial oxidative phosphorylation. Cell Death Discov 2021;7:166. [PMID: 34226508 DOI: 10.1038/s41420-021-00509-w] [Reference Citation Analysis]
122 Chen SW, Zhou HF, Zhang HJ, He RQ, Huang ZG, Dang YW, Yang X, Liu J, Fu ZW, Mo JX, Tang ZQ, Li CB, Li R, Yang LH, Ma J, Yang LJ, Chen G. The Clinical Significance and Potential Molecular Mechanism of PTTG1 in Esophageal Squamous Cell Carcinoma. Front Genet 2020;11:583085. [PMID: 33552118 DOI: 10.3389/fgene.2020.583085] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
123 Liu Z, Chen Z, Wang J, Zhang M, Li Z, Wang S, Dong B, Zhang C, Gao J, Shen L. Mouse avatar models of esophageal squamous cell carcinoma proved the potential for EGFR-TKI afatinib and uncovered Src family kinases involved in acquired resistance. J Hematol Oncol 2018;11:109. [PMID: 30157900 DOI: 10.1186/s13045-018-0651-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
124 Wang X, Lu Q, Fei X, Zhao Y, Shi B, Li C, Chen H. Expression and Prognostic Value of Id-4 in Patients with Esophageal Squamous Cell Carcinoma. Onco Targets Ther 2020;13:1225-34. [PMID: 32103990 DOI: 10.2147/OTT.S230678] [Reference Citation Analysis]
125 Trevellin E, Pirozzolo G, Fassan M, Vettor R. Prognostic value of stem cell markers in esophageal and esophagogastric junction cancer: a meta-analysis. J Cancer 2020;11:4240-9. [PMID: 32368307 DOI: 10.7150/jca.33699] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
126 Mashimo H, Gordon SR, Singh SK. Advanced endoscopic imaging for detecting and guiding therapy of early neoplasias of the esophagus. Ann N Y Acad Sci 2020;1482:61-76. [PMID: 33184872 DOI: 10.1111/nyas.14523] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
127 Zhang Y, Li J, Wang L, Meng P, Zhao J, Han P, Xia J, Xu J, Wang L, Shen F, Zheng A, Zhou F, Fan R. Clinical significance of detecting circulating tumor cells in patients with esophageal squamous cell carcinoma by EpCAM‑independent enrichment and immunostaining‑fluorescence in situ hybridization. Mol Med Rep 2019;20:1551-60. [PMID: 31257510 DOI: 10.3892/mmr.2019.10420] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
128 Chung TR, Kim JH, Lee IJ, Cho Y, Kim JW, Lee CG, Jung DH, Park JJ, Youn YH, Park H. Different prognosis of patients with esophageal carcinoma with M1a and regional node involvement. Dig Liver Dis 2019;51:1610-6. [PMID: 31175014 DOI: 10.1016/j.dld.2019.05.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
129 Dong Y, Yi X, Yujie Z, Huixia Z, Yan C. Relationship between the Methylation of Folic Acid Metabolism-Related Genes and the Incidence and Prognosis of Esophageal Cancer among Ethnic Kazakhs. J Cancer 2018;9:2865-75. [PMID: 30123355 DOI: 10.7150/jca.25270] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
130 Wang S, Yu P, Meng Z, Feng L. The value of microRNA-203 as a biomarker for the prognosis of esophageal cancer: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2020;99:e23599. [PMID: 33327325 DOI: 10.1097/MD.0000000000023599] [Reference Citation Analysis]
131 Kurtom S, Kaplan BJ. Esophagus and Gastrointestinal Junction Tumors. Surg Clin North Am 2020;100:507-21. [PMID: 32402297 DOI: 10.1016/j.suc.2020.02.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
132 Wang Y, Niu Z, Zhou L, Zhou Y, Ma Q, Zhu Y, Liu M, Shi Y, Tai Y, Shao Q, Ge J, Hua J, Gao L, Huang H, Jiang H, Sun Q. Subtype-Based Analysis of Cell-in-Cell Structures in Esophageal Squamous Cell Carcinoma. Front Oncol 2021;11:670051. [PMID: 34178655 DOI: 10.3389/fonc.2021.670051] [Reference Citation Analysis]
133 Li S, Chung DC, Mullen JT. Screening high-risk populations for esophageal and gastric cancer. J Surg Oncol. 2019;120:831-846. [PMID: 31373005 DOI: 10.1002/jso.25656] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
134 Yue M, Liu Y, Zuo T, Jiang Y, Pan J, Zhang S, Shen X. Circ_0006948 Contributes to Cell Growth, Migration, Invasion and Epithelial-Mesenchymal Transition in Esophageal Carcinoma. Dig Dis Sci 2021. [PMID: 33630215 DOI: 10.1007/s10620-021-06894-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
135 He F, Xiao H, Cai Y, Zhang N. ATF5 and HIF1α cooperatively activate HIF1 signaling pathway in esophageal cancer. Cell Commun Signal 2021;19:53. [PMID: 33980247 DOI: 10.1186/s12964-021-00734-x] [Reference Citation Analysis]
136 Vingeliene S, Chan DSM, Vieira AR, Polemiti E, Stevens C, Abar L, Navarro Rosenblatt D, Greenwood DC, Norat T. An update of the WCRF/AICR systematic literature review and meta-analysis on dietary and anthropometric factors and esophageal cancer risk. Ann Oncol. 2017;28:2409-2419. [PMID: 28666313 DOI: 10.1093/annonc/mdx338] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
137 Han L, Li YJ, Zhang WD, Song PP, Li H, Li S. Clinical significance of tumor cells in the peripheral blood of patients with esophageal squamous cell carcinoma. Medicine (Baltimore). 2019;98:e13921. [PMID: 30732126 DOI: 10.1097/md.0000000000013921] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
138 Morimoto Y, Kawakubo H, Ishikawa A, Matsuda S, Hijikata N, Ando M, Mayanagi S, Irino T, Nakamura R, Wada N, Tsuji T, Kitagawa Y. Short-term outcomes of robot-assisted minimally invasive esophagectomy with extended lymphadenectomy for esophageal cancer compared with video-assisted minimally invasive esophagectomy: A single-center retrospective study. Asian J Endosc Surg 2021. [PMID: 34637190 DOI: 10.1111/ases.12992] [Reference Citation Analysis]
139 Gong L, Mao W, Chen Q, Jiang Y, Fan Y. Analysis of SPARC and TUBB3 as predictors for prognosis in esophageal squamous cell carcinoma receiving nab-paclitaxel plus cisplatin neoadjuvant chemotherapy: a prospective study. Cancer Chemother Pharmacol. 2019;83:639-647. [PMID: 30643929 DOI: 10.1007/s00280-019-03769-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
140 Song H, Tetangco E, Ton L, Barrett A, Yap JEL. Beyond Squamous Cell Carcinoma: Basaloid Squamous Cell Carcinoma of the Esophagus. Cureus 2021;13:e12619. [PMID: 33585108 DOI: 10.7759/cureus.12619] [Reference Citation Analysis]
141 Mascitti M, Togni L, Troiano G, Caponio VCA, Gissi DB, Montebugnoli L, Procaccini M, Lo Muzio L, Santarelli A. Beyond Head and Neck Cancer: The Relationship Between Oral Microbiota and Tumour Development in Distant Organs. Front Cell Infect Microbiol 2019;9:232. [PMID: 31297343 DOI: 10.3389/fcimb.2019.00232] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 10.0] [Reference Citation Analysis]
142 He F, Wang J, Liu L, Qin X, Wan Z, Li W, Ping Z. Esophageal cancer: trends in incidence and mortality in China from 2005 to 2015. Cancer Med 2021;10:1839-47. [PMID: 33594825 DOI: 10.1002/cam4.3647] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
143 Eichelmann AK, Mayne GC, Chiam K, Due SL, Bastian I, Butz F, Wang T, Sykes PJ, Clemons NJ, Liu DS, Michael MZ, Karapetis CS, Hummel R, Watson DI, Hussey DJ. Mutant p53 Mediates Sensitivity to Cancer Treatment Agents in Oesophageal Adenocarcinoma Associated with MicroRNA and SLC7A11 Expression. Int J Mol Sci 2021;22:5547. [PMID: 34074015 DOI: 10.3390/ijms22115547] [Reference Citation Analysis]
144 Liang Y, Li S, Zheng G, Zhang L. β-elemene suppresses the malignant behavior of esophageal cancer cells by regulating the phosphorylation of AKT. Acta Histochemica 2020;122:151538. [DOI: 10.1016/j.acthis.2020.151538] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
145 Hassan MS, Awasthi N, Li J, Williams F, Schwarz MA, Schwarz RE, von Holzen U. Superior Therapeutic Efficacy of Nanoparticle Albumin Bound Paclitaxel Over Cremophor-Bound Paclitaxel in Experimental Esophageal Adenocarcinoma. Transl Oncol 2018;11:426-35. [PMID: 29475139 DOI: 10.1016/j.tranon.2018.01.022] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
146 Su HA, Hsiao SW, Hsu YC, Wang LY, Yen HH. Superiority of NBI endoscopy to PET/CT scan in detecting esophageal cancer among head and neck cancer patients: a retrospective cohort analysis. BMC Cancer 2020;20:69. [PMID: 31996171 DOI: 10.1186/s12885-020-6558-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
147 Wang J, Chen Y, Wu R, Lin Y. Circular RNA hsa_circ_0000554 promotes progression and elevates radioresistance through the miR-485-5p/fermitin family members 1 axis in esophageal cancer. Anticancer Drugs 2021;32:405-16. [PMID: 33470617 DOI: 10.1097/CAD.0000000000001007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
148 Shi N, Shan B, Gu B, Song Y, Chu H, Qian L. Circular RNA circ-PRKCI functions as a competitive endogenous RNA to regulate AKT3 expression by sponging miR-3680-3p in esophageal squamous cell carcinoma. J Cell Biochem. 2019;120:10021-10030. [PMID: 30659640 DOI: 10.1002/jcb.28285] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 8.3] [Reference Citation Analysis]
149 Jesinghaus M, Brühl F, Steiger K, Klare P, Reiser M, Scheiter A, Konukiewitz B, Kuhn P, Münch S, Quante M, Schmid RM, Wilhelm D, Feith M, Friess H, Combs SE, Saur D, Boxberg M, Weichert W. Cellular Dissociation Grading Based on the Parameters Tumor Budding and Cell Nest Size in Pretherapeutic Biopsy Specimens Allows for Prognostic Patient Stratification in Esophageal Squamous Cell Carcinoma Independent From Clinical Staging. Am J Surg Pathol 2019;43:618-27. [PMID: 30807302 DOI: 10.1097/PAS.0000000000001230] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
150 Wu X, Fan Y, Liu Y, Shen B, Lu H, Ma H. Long Non-Coding RNA CCAT2 Promotes the Development of Esophageal Squamous Cell Carcinoma by Inhibiting miR-200b to Upregulate the IGF2BP2/TK1 Axis. Front Oncol 2021;11:680642. [PMID: 34386421 DOI: 10.3389/fonc.2021.680642] [Reference Citation Analysis]
151 Liu Z, Zhao C, Du S, Gao S, Lu L. MiR-4262 inhibits the development of esophageal cancer by negatively regulating KLF6 level. Exp Mol Pathol 2020;115:104476. [PMID: 32473153 DOI: 10.1016/j.yexmp.2020.104476] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
152 Shi Q, Shen L, Dong B, Fu H, Kang X, Dai L, Yang Y, Yan W, Chen KN. Downregulation of HOXA13 sensitizes human esophageal squamous cell carcinoma to chemotherapy. Thorac Cancer 2018;9:836-46. [PMID: 29757528 DOI: 10.1111/1759-7714.12758] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
153 Zhao Q, Miao C, Lu Q, Wu W, He Y, Wu S, Liu H, Lian C. Clinical Significance of Monitoring Circulating Free DNA and Plasma Heat Shock Protein 90alpha in Patients with Esophageal Squamous Cell Carcinoma. Cancer Manag Res 2021;13:2223-34. [PMID: 33707971 DOI: 10.2147/CMAR.S295927] [Reference Citation Analysis]
154 Then EO, Lopez M, Saleem S, Gayam V, Sunkara T, Culliford A, Gaduputi V. Esophageal Cancer: An Updated Surveillance Epidemiology and End Results Database Analysis. World J Oncol 2020;11:55-64. [PMID: 32284773 DOI: 10.14740/wjon1254] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 17.5] [Reference Citation Analysis]
155 Ni Q, Chen P, Zhu B, Li J, Xie D, Ma X. Expression levels of EPHB4, EFNB2 and caspase-8 are associated with clinicopathological features and progression of esophageal squamous cell cancer. Oncol Lett 2020;19:917-29. [PMID: 31885720 DOI: 10.3892/ol.2019.11160] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
156 Tinusz B, Szapáry LB, Paládi B, Papp A, Bogner B, Hegedűs I, Bellyei S, Vincze Á, Solt J, Micsik T, Dunás-Varga V, Pályu E, Vass T, Schnabel T, Farkas N, Hegyi P, Thrift AP, Erőss B. The Esophageal Adenocarcinoma Epidemic Has Reached Hungary: A Multicenter, Cross-Sectional Study. Front Oncol 2020;10:541794. [PMID: 33425714 DOI: 10.3389/fonc.2020.541794] [Reference Citation Analysis]
157 Liu W, Zhang Y, Chen M, Shi L, Xu L, Zou X. A genome-wide analysis of long noncoding RNA profile identifies differentially expressed lncRNAs associated with Esophageal cancer. Cancer Med 2018;7:4181-9. [PMID: 29926523 DOI: 10.1002/cam4.1536] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
158 Li J, Zhu H, Yang Q, Xiao H, Wu H, Fang Z, Li W, Cai M, Wang F. Identification of Molecular Subtypes and Potential Small-Molecule Drugs for Esophagus Cancer Treatment Based on m6A Regulators. Journal of Oncology 2022;2022:1-13. [DOI: 10.1155/2022/5490461] [Reference Citation Analysis]
159 Visser E, Franken IA, Brosens LAA, de Leng WWJ, Strengman E, Offerhaus JA, Ruurda JP, van Hillegersberg R. Targeted next-generation sequencing of commonly mutated genes in esophageal adenocarcinoma patients with long-term survival. Dis Esophagus 2017;30:1-8. [PMID: 28859360 DOI: 10.1093/dote/dox058] [Reference Citation Analysis]
160 Okada M, Ishimura N, Mikami H, Okimoto E, Oshima N, Miyaoka Y, Fujishiro H, Ishihara S, Kinoshita Y. Circumferential distribution and clinical characteristics of esophageal cancer in lower esophagus: differences related to histological subtype. Esophagus 2019;16:98-106. [DOI: 10.1007/s10388-018-0639-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
161 Łukaszewicz-Zając M, Pączek S, Mroczko B. The significance of chemokine CXCL-8 in esophageal carcinoma. Arch Med Sci 2020;16:475-80. [PMID: 32190161 DOI: 10.5114/aoms.2017.71933] [Reference Citation Analysis]
162 Zhang H, Huang Z, Song Y, Yang Z, Shi Q, Wang K, Zhang Z, Liu Z, Cui X, Li F. The TP53-Related Signature Predicts Immune Cell Infiltration, Therapeutic Response, and Prognosis in Patients With Esophageal Carcinoma. Front Genet 2021;12:607238. [PMID: 34234806 DOI: 10.3389/fgene.2021.607238] [Reference Citation Analysis]
163 Wang L, Wei Q, Zhang M, Chen L, Li Z, Zhou C, He M, Wei M, Zhao L. Identification of the prognostic value of immune gene signature and infiltrating immune cells for esophageal cancer patients. Int Immunopharmacol 2020;87:106795. [PMID: 32707495 DOI: 10.1016/j.intimp.2020.106795] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
164 Li X, Yang H, Wang J, Li X, Fan Z, Zhao J, Liu L, Zhang M, Goscinski MA, Wang J, Xu R, Fan H, Li H, Suo Z. High level of lncRNA H19 expression is associated with shorter survival in esophageal squamous cell cancer patients. Pathol Res Pract 2019;215:152638. [PMID: 31551175 DOI: 10.1016/j.prp.2019.152638] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
165 Zhao C, Zhou J, Gu Y, Pan E, Sun Z, Zhang H, Lu Q, Zhang Y, Yu X, Liu R, Pu Y, Yin L. Urinary exposure of N-nitrosamines and associated risk of esophageal cancer in a high incidence area in China. Science of The Total Environment 2020;738:139713. [DOI: 10.1016/j.scitotenv.2020.139713] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
166 Lin WC, Chang CL, Hsu HL, Yuan KS, Wu ATH, Wu SY. Three-Dimensional Conformal Radiotherapy-Based or Intensity-Modulated Radiotherapy-Based Concurrent Chemoradiotherapy in Patients with Thoracic Esophageal Squamous Cell Carcinoma. Cancers (Basel) 2019;11:E1529. [PMID: 31658709 DOI: 10.3390/cancers11101529] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
167 Sun X, Niwa T, Ozawa S, Endo J, Hashimoto J. Detecting lymph node metastasis of esophageal cancer on dual-energy computed tomography. Acta Radiol 2020;:284185120980144. [PMID: 33325727 DOI: 10.1177/0284185120980144] [Reference Citation Analysis]
168 Sherry AD, Newman NB, Anderson JL, Osmundson EC. Systemic inflammatory dynamics during chemoradiotherapy predict response, relapse, metastasis, and survival in esophageal carcinoma. J Surg Oncol 2019;121:303-12. [DOI: 10.1002/jso.25793] [Cited by in Crossref: 4] [Article Influence: 1.3] [Reference Citation Analysis]
169 Zare M, Hadi F, Alivand MR. Considering the downregulation of Tpm1.6 and Tpm1.7 in squamous cell carcinoma of esophagus as a potent biomarker. Per Med 2018;15:361-70. [PMID: 30259780 DOI: 10.2217/pme-2018-0015] [Reference Citation Analysis]
170 Wang F, Zhang L, Xu Y, Xie Y, Li S. Comprehensive Analysis and Identification of Key Driver Genes for Distinguishing Between Esophageal Adenocarcinoma and Squamous Cell Carcinoma. Front Cell Dev Biol 2021;9:676156. [PMID: 34124063 DOI: 10.3389/fcell.2021.676156] [Reference Citation Analysis]
171 Martin-Richard M, Díaz Beveridge R, Arrazubi V, Alsina M, Galan Guzmán M, Custodio AB, Gómez C, Muñoz FL, Pazo R, Rivera F. SEOM Clinical Guideline for the diagnosis and treatment of esophageal cancer (2016). Clin Transl Oncol 2016;18:1179-86. [PMID: 27900538 DOI: 10.1007/s12094-016-1577-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
172 Li Z, Xu H, Yu J, Liu C, Zheng C, Zeng R, Xu L, Li E, Peng Y, Xu Y. The Early Diagnostic Value of Serum Interleukin-8 in Esophagogastric Junction Adenocarcinoma. Cancer Control 2021;28:10732748211004883. [PMID: 33926265 DOI: 10.1177/10732748211004883] [Reference Citation Analysis]
173 Ueda C, Yosizaki T, Katayama N, Okamoto N, Hashimura H, Matsumoto M, Takagi M, Ikeoka S, Momose K, Eguchi T, Yamashita H, Okada A. Barrett's adenocarcinoma with esophageal varices successfully treated by endoscopic submucosal dissection with direct varices coagulation. Clin J Gastroenterol 2020;13:178-81. [PMID: 31559540 DOI: 10.1007/s12328-019-01048-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
174 Yang F, Wei K, Qin Z, Shao C, Shu Y, Shen H. Association between TNF-ɑ-308G/A polymorphism and esophageal cancer risk: An updated meta-analysis and trial sequential analysis. J Cancer 2019;10:1086-96. [PMID: 30854115 DOI: 10.7150/jca.29390] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
175 Okereke IC, Miller AL, Jupiter DC, Hamilton CF, Reep GL, Krill T, Andersen CR, Pyles RB. Microbiota Detection Patterns Correlate With Presence and Severity of Barrett's Esophagus. Front Cell Infect Microbiol 2021;11:555072. [PMID: 33708643 DOI: 10.3389/fcimb.2021.555072] [Reference Citation Analysis]
176 Guan L, Zou Q, Liu Q, Chen S. [Comparison of B-NDG? and BALB/c mouse models bearing patient-derived xenografts of esophageal squamous cell carcinoma]. Nan Fang Yi Ke Da Xue Xue Bao 2020;40:1200-6. [PMID: 32895183 DOI: 10.12122/j.issn.1673-4254.2020.08.19] [Reference Citation Analysis]
177 Li J, Dong G, Song J, Tan G, Wu X. Telomerase inhibition decreases esophageal squamous carcinoma cell migration and invasion. Oncol Lett 2020;20:2870-80. [PMID: 32782603 DOI: 10.3892/ol.2020.11810] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
178 Hou X, Li T, Ren Z, Liu Y. Novel BRCA2-Interacting Protein, LIMD1, Is Essential for the Centrosome Localization of BRCA2 in Esophageal Cancer Cell. Oncol Res 2016;24:247-53. [PMID: 27656835 DOI: 10.3727/096504016X14652175055765] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
179 Antoine AR, Joyce S, Joanna S, Christine K, Khoury Salem E, Philippe S. Gastrointestinal cancer characteristics in Lebanon. Arab J Gastroenterol 2021:S1687-1979(21)00065-4. [PMID: 34509388 DOI: 10.1016/j.ajg.2021.08.001] [Reference Citation Analysis]
180 Zhang D, Li C, Cheng N, Sun L, Zhou X, Pan G, Zhao J. CircAGFG1 acts as a sponge of miR-4306 to stimulate esophageal cancer progression by modulating MAPRE2 expression. Acta Histochem 2021;123:151776. [PMID: 34461454 DOI: 10.1016/j.acthis.2021.151776] [Reference Citation Analysis]
181 Saad AM, Al-Husseini MJ, Elgebaly A, Aboshady OA, Salahia S, Abdel-Rahman O. Impact of prior malignancy on outcomes of stage IV esophageal carcinoma: SEER based study. Expert Rev Gastroenterol Hepatol 2018;12:417-23. [PMID: 29316808 DOI: 10.1080/17474124.2018.1426458] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
182 Wang F, Ding X, Wang T, Shan Z, Wang J, Wu S, Chi Y, Zhang Y, Lv Z, Wang L, Fan Q. Metformin inhibited esophageal squamous cell carcinoma proliferation in vitro and in vivo and enhanced the anti-cancer effect of cisplatin. PLoS One 2017;12:e0174276. [PMID: 28406985 DOI: 10.1371/journal.pone.0174276] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
183 Zhang M, Zhang L, Cui M, Ye W, Zhang P, Zhou S, Wang J. miR-302b inhibits cancer-related inflammation by targeting ERBB4, IRF2 and CXCR4 in esophageal cancer. Oncotarget 2017;8:49053-63. [PMID: 28467773 DOI: 10.18632/oncotarget.17041] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
184 Sui H, Ma R, Liu L, Gao Y, Zhang W, Mo Z. Detection of Incidental Esophageal Cancers on Chest CT by Deep Learning. Front Oncol 2021;11:700210. [PMID: 34604036 DOI: 10.3389/fonc.2021.700210] [Reference Citation Analysis]
185 Shi H, Ma S, Zhao P, Jiang J, Cheng Y, Zhao J, Wang J, Qiao Z, Jiang J, Li S, Wu J. Endoscopic ultrasonography for preoperative staging of esophageal carcinoma. Scand J Gastroenterol 2017;52:1052-6. [PMID: 28625089 DOI: 10.1080/00365521.2017.1339829] [Reference Citation Analysis]
186 Liu G, Guo W, Chen G, Li W, Cui Y, Qin J, Peng J. Lnc-MCEI mediated the chemosensitivity of esophageal squamous cell carcinoma via miR-6759-5p to competitively regulate IGF2. Int J Biol Sci 2020;16:2938-50. [PMID: 33061807 DOI: 10.7150/ijbs.47051] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
187 Wang J, Yu L, Sun Y, Zhang L, Tu M, Cai L, Yin X, Pan X, Wang T, Huang Y. Development and Evaluation of Serum CST1 Detection for Early Diagnosis of Esophageal Squamous Cell Carcinoma. Cancer Manag Res 2021;13:8341-52. [PMID: 34764696 DOI: 10.2147/CMAR.S337497] [Reference Citation Analysis]
188 Zhang D, Wu J, Wang H, Zhou W, Ni M, Liu X, Zhang X. Systematic review and network meta-analysis comparing Chinese herbal injections with chemotherapy for treating patients with esophageal cancer. J Int Med Res 2020;48:300060519898336. [PMID: 31948305 DOI: 10.1177/0300060519898336] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
189 Zhang H, Li H, Ma Q, Yang FY, Diao TY. Predicting malignant transformation of esophageal squamous cell lesions by combined biomarkers in an endoscopic screening program. World J Gastroenterol 2016; 22(39): 8770-8778 [PMID: 27818592 DOI: 10.3748/wjg.v22.i39.8770] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
190 Chen J, Nguyen VP, Jaiswal S, Kang X, Lee M, Paulus YM, Wang TD. Thin Layer-Protected Gold Nanoparticles for Targeted Multimodal Imaging with Photoacoustic and CT. Pharmaceuticals (Basel) 2021;14:1075. [PMID: 34832857 DOI: 10.3390/ph14111075] [Reference Citation Analysis]
191 Tullio V, Gasperi V, Catani MV, Savini I. The Impact of Whole Grain Intake on Gastrointestinal Tumors: A Focus on Colorectal, Gastric, and Esophageal Cancers. Nutrients 2020;13:E81. [PMID: 33383776 DOI: 10.3390/nu13010081] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
192 Delman AM, Ammann AM, Turner KM, Vaysburg DM, Van Haren RM. A narrative review of socioeconomic disparities in the treatment of esophageal cancer. J Thorac Dis 2021;13:3801-8. [PMID: 34277070 DOI: 10.21037/jtd-20-3095] [Reference Citation Analysis]
193 Peng H, Wang LG, Wang XZ, Liu AJ. The correlation between XIAP gene polymorphisms and esophageal squamous cell carcinoma susceptibility and prognosis in a Chinese population. Pathol Res Pract 2017;213:1482-8. [PMID: 29037837 DOI: 10.1016/j.prp.2017.10.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
194 Bie J, Hu X, Yang M, Shi X, Zhang X, Wang Z. PTK7 promotes the malignant properties of cancer stem-like cells in esophageal squamous cell lines. Hum Cell 2020;33:356-65. [PMID: 31894477 DOI: 10.1007/s13577-019-00309-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
195 Ye ZM, Dai SJ, Yan FQ, Wang L, Fang J, Fu ZF, Wang YZ. DCE-MRI-Derived Volume Transfer Constant (Ktrans) and DWI Apparent Diffusion Coefficient as Predictive Markers of Short- and Long-Term Efficacy of Chemoradiotherapy in Patients With Esophageal Cancer. Technol Cancer Res Treat 2018;17:1533034618765254. [PMID: 29642773 DOI: 10.1177/1533034618765254] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
196 Thrift AP. Global burden and epidemiology of Barrett oesophagus and oesophageal cancer. Nat Rev Gastroenterol Hepatol 2021;18:432-43. [PMID: 33603224 DOI: 10.1038/s41575-021-00419-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
197 Liu M, Zhou R, Guo C, Xu R, Liu A, Yang H, Li F, Duan L, Shen L, Wu Q, Liu Z, Liu F, Liu Y, Pan Y, Cai H, Weiss NS, He Z, Ke Y. Size of Lugol-unstained lesions as a predictor for risk of progression in premalignant lesions of the esophagus. Gastrointest Endosc 2021;93:1065-1073.e3. [PMID: 32950597 DOI: 10.1016/j.gie.2020.09.020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
198 Papaconstantinou D, Tsilimigras DI, Moris D, Michalinos A, Mastoraki A, Mpaili E, Hasemaki N, Bakopoulos A, Filippou D, Schizas D. Synchronous resection of esophageal cancer and other organ malignancies: A systematic review. World J Gastroenterol 2019; 25(26): 3438-3449 [PMID: 31341367 DOI: 10.3748/wjg.v25.i26.3438] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
199 Zeng Q, Zhu Z, Song L, He Z. Transferred by exosomes-derived MiR-19b-3p targets PTEN to regulate esophageal cancer cell apoptosis, migration and invasion. Biosci Rep 2020;40:BSR20201858. [PMID: 33146702 DOI: 10.1042/BSR20201858] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
200 Panebianco C, Potenza A, Andriulli A, Pazienza V. Exploring the microbiota to better understand gastrointestinal cancers physiology. Clin Chem Lab Med 2018;56:1400-12. [PMID: 29630505 DOI: 10.1515/cclm-2017-1163] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
201 Xu D, Li G, Li H, Jia F. Comparison of IMRT versus 3D-CRT in the treatment of esophagus cancer: A systematic review and meta-analysis. Medicine (Baltimore) 2017;96:e7685. [PMID: 28767597 DOI: 10.1097/MD.0000000000007685] [Cited by in Crossref: 30] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
202 Xu QR, Tang J, Liao HY, Yu BT, He XY, Zheng YZ, Liu S. Long non-coding RNA MEG3 mediates the miR-149-3p/FOXP3 axis by reducing p53 ubiquitination to exert a suppressive effect on regulatory T cell differentiation and immune escape in esophageal cancer. J Transl Med 2021;19:264. [PMID: 34140005 DOI: 10.1186/s12967-021-02907-1] [Reference Citation Analysis]
203 Kawasaki M, Ikeda Y, Ikeda E, Takahashi M, Tanaka D, Nakajima Y, Arakawa S, Izumi Y, Miyake S. Oral infectious bacteria in dental plaque and saliva as risk factors in patients with esophageal cancer. Cancer 2021;127:512-9. [PMID: 33156979 DOI: 10.1002/cncr.33316] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
204 Zarean E, Azizmohammad Looha M, Amini P, Mahmoudi M, Azimi T. Factors Affecting Long-Survival of Patients with Esophageal Cancer Using Non-Mixture Cure Fraction Model. Asian Pac J Cancer Prev 2018;19:1677-83. [PMID: 29938465 DOI: 10.22034/APJCP.2018.19.6.1677] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
205 Boon SS, Chen Z, Li J, Lee KYC, Cai L, Zhong R, Chan PKS. Human papillomavirus type 18 oncoproteins exert their oncogenicity in esophageal and tongue squamous cell carcinoma cell lines distinctly. BMC Cancer 2019;19:1211. [PMID: 31830929 DOI: 10.1186/s12885-019-6413-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
206 Laursen L, Schønau MN, Bergenholtz HM, Siemsen M, Christensen M, Missel M. Table in the corner: a qualitative study of life situation and perspectives of the everyday lives of oesophageal cancer patients in palliative care. BMC Palliat Care 2019;18:60. [PMID: 31331302 DOI: 10.1186/s12904-019-0445-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
207 Chen Z, Hu X, Wu Y, Cong L, He X, Lu J, Feng J, Liu D. Long non-coding RNA XIST promotes the development of esophageal cancer by sponging miR-494 to regulate CDK6 expression. Biomedicine & Pharmacotherapy 2019;109:2228-36. [DOI: 10.1016/j.biopha.2018.11.049] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 8.0] [Reference Citation Analysis]
208 Łukaszewicz-Zając M, Mroczko B, Kozłowski M, Szmitkowski M. The Serum Concentrations of Chemokine CXCL12 and Its Specific Receptor CXCR4 in Patients with Esophageal Cancer. Dis Markers 2016;2016:7963895. [PMID: 27041792 DOI: 10.1155/2016/7963895] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
209 Charalampakis N, Tsakatikas S, Schizas D, Kykalos S, Tolia M, Fioretzaki R, Papageorgiou G, Katsaros I, Abdelhakeem AAF, Sewastjanow-Silva M, Rogers JE, Ajani JA. Trimodality treatment in gastric and gastroesophageal junction cancers: Current approach and future perspectives. World J Gastrointest Oncol 2022; 14(1): 181-202 [DOI: 10.4251/wjgo.v14.i1.181] [Reference Citation Analysis]
210 Wang H. A Review of the Effects of Collagen Treatment in Clinical Studies. Polymers (Basel) 2021;13:3868. [PMID: 34833168 DOI: 10.3390/polym13223868] [Reference Citation Analysis]
211 Chen ZX, Li GS, Yang LH, Liu HC, Qin GM, Shen L, He WY, Gan TQ, Li JJ. Upregulation of BIRC5 plays essential role in esophageal squamous cell carcinoma. Math Biosci Eng 2021;18:6941-60. [PMID: 34517565 DOI: 10.3934/mbe.2021345] [Reference Citation Analysis]
212 Salem ME, Puccini A, Xiu J, Raghavan D, Lenz HJ, Korn WM, Shields AF, Philip PA, Marshall JL, Goldberg RM. Comparative Molecular Analyses of Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, and Gastric Adenocarcinoma. Oncologist. 2018;23:1319-1327. [PMID: 29866946 DOI: 10.1634/theoncologist.2018-0143] [Cited by in Crossref: 36] [Cited by in F6Publishing: 45] [Article Influence: 9.0] [Reference Citation Analysis]
213 Moon H, White AC, Borowsky AD. New insights into the functions of Cox-2 in skin and esophageal malignancies. Exp Mol Med 2020;52:538-47. [PMID: 32235869 DOI: 10.1038/s12276-020-0412-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
214 Nimptsch K, Steffen A, Pischon T. Obesity and Oesophageal Cancer. Recent Results Cancer Res 2016;208:67-80. [PMID: 27909902 DOI: 10.1007/978-3-319-42542-9_4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
215 Deana C, Vetrugno L, Bignami E, Bassi F. Peri-operative approach to esophagectomy: a narrative review from the anesthesiological standpoint. J Thorac Dis 2021;13:6037-51. [PMID: 34795950 DOI: 10.21037/jtd-21-940] [Reference Citation Analysis]
216 Boldrin E, Malacrida S, Rumiato E, Battaglia G, Ruol A, Amadori A, Saggioro D. Association Between ERCC1 rs3212986 and ERCC2/XPD rs1799793 and OS in Patients With Advanced Esophageal Cancer. Front Oncol 2019;9:85. [PMID: 30847299 DOI: 10.3389/fonc.2019.00085] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
217 Xing J, Min L, Zhang H, Li P, Li W, Lv F, Wang Y, Zhang Z, Li H, Guo Q, Wang S, Zhao Y, Wang J, Shi X, Wang A, Zhu S, Ji M, Wu Y, Zhang S; NCECS Study Group. A nomogram for endoscopic screening in a high esophageal squamous cell cancer risk area: results from a population-based study. Cancer Manag Res 2019;11:431-42. [PMID: 30655695 DOI: 10.2147/CMAR.S167311] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
218 Kanda M, Koike M, Shimizu D, Tanaka C, Hattori N, Hayashi M, Yamada S, Omae K, Kodera Y. Characteristics Associated with Nodal and Distant Recurrence After Radical Esophagectomy for Squamous Cell Carcinoma of the Thoracic Esophagus. Ann Surg Oncol 2020;27:3195-205. [PMID: 32246314 DOI: 10.1245/s10434-020-08433-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
219 Han X, Lu Y, Fang Q, Fang P, Wong GTC, Liu X. Effects of Epidural Anesthesia on Quality of Life in Elderly Patients Undergoing Esophagectomy. Seminars in Thoracic and Cardiovascular Surgery 2021;33:276-85. [DOI: 10.1053/j.semtcvs.2020.08.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
220 Fiocca R, Mastracci L, Lugaresi M, Grillo F, D'Errico A, Malvi D, Spaggiari P, Tomezzoli A, Albarello L, Ristimäki A, Bottiglieri L, Bonora E, Krishnadath KK, Raulli GD, Rosati R, Fumagalli Romario U, De Manzoni G, Räsänen J, Mattioli S. The Prognostic Impact of Histology in Esophageal and Esophago-Gastric Junction Adenocarcinoma. Cancers (Basel) 2021;13:5211. [PMID: 34680360 DOI: 10.3390/cancers13205211] [Reference Citation Analysis]
221 Li X, Ren Z, Xiong C, Geng J, Li Y, Liu C, Ren C, Liu H. Minichromosome maintenance 6 complex component identified by bioinformatics analysis and experimental validation in esophageal squamous cell carcinoma. Oncol Rep 2020;44:987-1002. [PMID: 32583000 DOI: 10.3892/or.2020.7658] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
222 Yang X, Tian M, Zhang W, Chai T, Shen Z, Kang M, Lin J. Identification of potential core genes in esophageal carcinoma using bioinformatics analysis. Medicine (Baltimore) 2021;100:e26428. [PMID: 34232175 DOI: 10.1097/MD.0000000000026428] [Reference Citation Analysis]
223 Su P, Wen S, Zhang Y, Li Y, Xu Y, Zhu Y, Lv H, Zhang F, Wang M, Tian Z. Identification of the Key Genes and Pathways in Esophageal Carcinoma. Gastroenterol Res Pract 2016;2016:2968106. [PMID: 27818681 DOI: 10.1155/2016/2968106] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
224 Dai F, Liu T, Zheng S, Liu Q, Yang C, Zhou J, Chen Y, Sheyhidin I, Lu X. MiR-106b promotes migration and invasion through enhancing EMT via downregulation of Smad 7 in Kazakh's esophageal squamous cell carcinoma. Tumour Biol. 2016;37:14595-14604. [PMID: 27619676 DOI: 10.1007/s13277-016-5338-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
225 Gao XX, Gao L, Wang JQ, Qu SS, Qu Y, Sun HL, Liu SD, Shang YL. Convergent evidence from systematic analysis of GWAS revealed genetic basis of esophageal cancer. Oncotarget 2016;7:44621-9. [PMID: 27331408 DOI: 10.18632/oncotarget.10133] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
226 Chen M, Dang Y, Ding C, Yang J, Si X, Zhang G. Lesion size and circumferential range identified as independent risk factors for esophageal stricture after endoscopic submucosal dissection. Surg Endosc 2020;34:4065-71. [PMID: 31953729 DOI: 10.1007/s00464-020-07368-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
227 Pan D, Su M, Huang G, Luo P, Zhang T, Fu L, Wei J, Wang S, Sun G. MTHFR C677T genetic polymorphism in combination with serum vitamin B2, B12 and aberrant DNA methylation of P16 and P53 genes in esophageal squamous cell carcinoma and esophageal precancerous lesions: a case-control study. Cancer Cell Int 2019;19:288. [PMID: 31754346 DOI: 10.1186/s12935-019-1012-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
228 Yan SM, Liu L, Gu WY, Huang LY, Yang Y, Huang YH, Luo RZ. CEP55 Positively Affects Tumorigenesis of Esophageal Squamous Cell Carcinoma and Is Correlated with Poor Prognosis. J Oncol 2021;2021:8890715. [PMID: 34104194 DOI: 10.1155/2021/8890715] [Reference Citation Analysis]
229 Du H, Xie S, Guo W, Che J, Zhu L, Hang J, Li H. Development and validation of an autophagy-related prognostic signature in esophageal cancer. Ann Transl Med 2021;9:317. [PMID: 33708944 DOI: 10.21037/atm-20-4541] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
230 Jesinghaus M, Boxberg M, Wilhelm D, Münch S, Dapper H, Quante M, Schlag C, Lange S, Budczies J, Konukiewitz B, Mollenhauer M, Schlitter AM, Becker KF, Feith M, Friess H, Steiger K, Combs SE, Weichert W. Post-neoadjuvant cellular dissociation grading based on tumour budding and cell nest size is associated with therapy response and survival in oesophageal squamous cell carcinoma. Br J Cancer 2019;121:1050-7. [PMID: 31690830 DOI: 10.1038/s41416-019-0623-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
231 Rasic P, Jovanovic-Tucovic M, Jeremic M, Djuricic SM, Vasiljevic ZV, Milickovic M, Savic D. B7 homologue 3 as a prognostic biomarker and potential therapeutic target in gastrointestinal tumors. World J Gastrointest Oncol 2021; 13(8): 799-821 [PMID: 34457187 DOI: 10.4251/wjgo.v13.i8.799] [Reference Citation Analysis]
232 Zang YQ, Zhai YQ, Feng YY, Ju XY, Zuo F. Molecular mechanisms of quinalizarin induces apoptosis and G0/G1 cell cycle of human esophageal cancer HCE-4 cells depends on MAPK, STAT3, and NF-κB signaling pathways. Environ Toxicol 2021;36:276-86. [PMID: 33030807 DOI: 10.1002/tox.23033] [Reference Citation Analysis]
233 Khoshghamat N, Jafari N, Moetamani-Ahmadi M, Khalili-Tanha G, Khajavi Rad MH, Sahebdel S, Khalili-Tanha N, Soleimanpour S, Khazaei M, Hassanian SM, Ferns GA, Avan A. Programmed cell death 1 as prognostic marker and therapeutic target in upper gastrointestinal cancers. Pathol Res Pract 2021;220:153390. [PMID: 33640713 DOI: 10.1016/j.prp.2021.153390] [Reference Citation Analysis]
234 Lu Y, Guan L, Xu M, Wang F. The efficacy and safety of antibodies targeting PD-1 for treatment in advanced esophageal cancer: A systematic review and meta-analysis. Transl Oncol 2021;14:101083. [PMID: 33784583 DOI: 10.1016/j.tranon.2021.101083] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
235 Li Z, Dong K, Guo P, Tan Z, Zhang F, Tian Y, Lv H. Identification of Autophagy-Related Genes and Small-Molecule Drugs in Esophageal Carcinoma. Med Sci Monit 2020;26:e921855. [PMID: 32415055 DOI: 10.12659/MSM.921855] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
236 Visser E, Franken IA, Brosens LA, Ruurda JP, van Hillegersberg R. Prognostic gene expression profiling in esophageal cancer: a systematic review.Oncotarget. 2017;8:5566-5577. [PMID: 27852047 DOI: 10.18632/oncotarget.13328] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 5.8] [Reference Citation Analysis]
237 Li Y, Zhu X, Yang M, Wang Y, Li J, Fang J, Guo W, Ma S, Guan F. YAP/TEAD4-induced KIF4A contributes to the progression and worse prognosis of esophageal squamous cell carcinoma. Mol Carcinog 2021;60:440-54. [PMID: 34003522 DOI: 10.1002/mc.23303] [Reference Citation Analysis]
238 Zhang L, Wang F, Yi H, Ermakova SP, Malyarenko OS, Mo J, Huang Y, Duan Q, Xiao J, Zhu F. The role of T-LAK cell-originated protein kinase in targeted cancer therapy. Mol Cell Biochem 2022. [PMID: 35037144 DOI: 10.1007/s11010-021-04329-5] [Reference Citation Analysis]
239 Yamazato Y, Shiozaki A, Ichikawa D, Kosuga T, Shoda K, Arita T, Konishi H, Komatsu S, Kubota T, Fujiwara H, Okamoto K, Kishimoto M, Konishi E, Marunaka Y, Otsuji E. Aquaporin 1 suppresses apoptosis and affects prognosis in esophageal squamous cell carcinoma. Oncotarget 2018;9:29957-74. [PMID: 30042826 DOI: 10.18632/oncotarget.25722] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
240 Schizas D, Mastoraki A, Naar L, Spartalis E, Tsilimigras DI, Karachaliou GS, Bagias G, Moris D. Concept of histone deacetylases in cancer: Reflections on esophageal carcinogenesis and treatment. World J Gastroenterol 2018; 24(41): 4635-4642 [PMID: 30416311 DOI: 10.3748/wjg.v24.i41.4635] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
241 Ma Y, Wang B, Guo Y, Zhang Y, Huang S, Bao X, Bai M. Inhibition of miR-196a affects esophageal cancer cell growth in vitro. Biomedicine & Pharmacotherapy 2016;84:22-7. [DOI: 10.1016/j.biopha.2016.09.013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
242 Yang Z, Wang D, Zhang C, Liu H, Hao M, Kan S, Liu D, Liu W. The Applications of Gold Nanoparticles in the Diagnosis and Treatment of Gastrointestinal Cancer. Front Oncol 2022;11:819329. [DOI: 10.3389/fonc.2021.819329] [Reference Citation Analysis]
243 Buller ID, Patel DM, Weyer PJ, Prizment A, Jones RR, Ward MH. Ingestion of Nitrate and Nitrite and Risk of Stomach and Other Digestive System Cancers in the Iowa Women's Health Study. Int J Environ Res Public Health 2021;18:6822. [PMID: 34202037 DOI: 10.3390/ijerph18136822] [Reference Citation Analysis]
244 Zhan W, Li H, Guo Y, Du G, Wu Y, Zhang D. Construction of Biocompatible Dual-Drug Loaded Complicated Nanoparticles for in vivo Improvement of Synergistic Chemotherapy in Esophageal Cancer. Front Oncol 2020;10:622. [PMID: 32432038 DOI: 10.3389/fonc.2020.00622] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
245 Schulze J, Melzer L, Smith L, Teschke R. Green Tea and Its Extracts in Cancer Prevention and Treatment. Beverages 2017;3:17. [DOI: 10.3390/beverages3010017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.4] [Reference Citation Analysis]
246 Marlicz W, Ren X, Robertson A, Skonieczna-Żydecka K, Łoniewski I, Dario P, Wang S, Plevris JN, Koulaouzidis A, Ciuti G. Frontiers of Robotic Gastroscopy: A Comprehensive Review of Robotic Gastroscopes and Technologies. Cancers (Basel) 2020;12:E2775. [PMID: 32998213 DOI: 10.3390/cancers12102775] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
247 Wang G, Li Q, Li C, Duan G, Sang H, Dong H, Yang Y, Ma C, Tao T. Knockdown of PNO1 inhibits esophageal cancer progression. Oncol Rep 2021;45:85. [PMID: 33864661 DOI: 10.3892/or.2021.8036] [Reference Citation Analysis]
248 Jeong S, Bak J, Kim SM, Kang HW. Feasibility study of endoscopic thermal coagulation with circumferential laser irradiation for treating esophageal tissue. Lasers Med Sci 2020;35:893-900. [PMID: 31641966 DOI: 10.1007/s10103-019-02877-3] [Reference Citation Analysis]
249 Wirsching A, Boshier PR, Krishnamoorthi R, Larsen MC, Irani S, Ross AS, Low DE. Endoscopic therapy and surveillance versus esophagectomy for early esophageal adenocarcinoma: A review of early outcomes and cost analysis. Am J Surg. 2019;218:164-169. [PMID: 30635212 DOI: 10.1016/j.amjsurg.2018.12.058] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
250 Liu HE, Shi HH, Luo XJ. Upregulated Long Noncoding RNA UCA1 Enhances Warburg Effect via miR-203/HK2 Axis in Esophagal Cancer. J Oncol 2020;2020:8847687. [PMID: 33204264 DOI: 10.1155/2020/8847687] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
251 Chen L, Zhao T. Identification of KHSRP-Regulated RNAs in Esophageal Cancer by Integrated Bioinformatics Analysis. Cancer Biother Radiopharm 2021;36:412-24. [PMID: 32673063 DOI: 10.1089/cbr.2020.3745] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
252 Li J, Wu H, Gao H, Kou R, Xie Y, Zhang Z, Zhang X. TLR4 promoter rs1927914 variant contributes to the susceptibility of esophageal squamous cell carcinoma in the Chinese population. PeerJ 2021;9:e10754. [PMID: 33585082 DOI: 10.7717/peerj.10754] [Reference Citation Analysis]
253 Bai Y, Zhu P, Zhou K, Zhang SG. Effect of the acid suppressor omeprazole on the proliferation, migration, invasion and cell cycle of esophageal squamous cell carcinoma cells via the aryl hydrocarbon receptor pathway. Exp Ther Med 2021;22:1187. [PMID: 34475977 DOI: 10.3892/etm.2021.10621] [Reference Citation Analysis]
254 Yu-Jing T, Wen-Jing T, Biao T. Integrated Analysis of Hub Genes and Pathways In Esophageal Carcinoma Based on NCBI's Gene Expression Omnibus (GEO) Database: A Bioinformatics Analysis. Med Sci Monit 2020;26:e923934. [PMID: 32756534 DOI: 10.12659/MSM.923934] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
255 Lu G, Chen L, Wu S, Feng Y, Lin T. Comprehensive Analysis of Tumor-Infiltrating Immune Cells and Relevant Therapeutic Strategy in Esophageal Cancer. Dis Markers 2020;2020:8974793. [PMID: 32454908 DOI: 10.1155/2020/8974793] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
256 Chen C, Peng H, Huang X, Zhao M, Li Z, Yin N, Wang X, Yu F, Yin B, Yuan Y, Lu Q. Genome-wide profiling of DNA methylation and gene expression in esophageal squamous cell carcinoma. Oncotarget 2016;7:4507-21. [PMID: 26683359 DOI: 10.18632/oncotarget.6607] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
257 Emura F, Sharma P, Arantes V, Cerisoli C, Parra-Blanco A, Sumiyama K, Araya R, Sobrino S, Chiu P, Matsuda K, Gonzalez R, Fujishiro M, Tajiri H. Principles and practice to facilitate complete photodocumentation of the upper gastrointestinal tract: World Endoscopy Organization position statement. Dig Endosc 2020;32:168-79. [PMID: 31529547 DOI: 10.1111/den.13530] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
258 Uhlenhopp DJ, Then EO, Sunkara T, Gaduputi V. Epidemiology of esophageal cancer: update in global trends, etiology and risk factors. Clin J Gastroenterol 2020;13:1010-21. [PMID: 32965635 DOI: 10.1007/s12328-020-01237-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 10.5] [Reference Citation Analysis]
259 Kwak AW, Yoon G, Lee MH, Cho SS, Shim JH, Chae JI. Picropodophyllotoxin, an Epimer of Podophyllotoxin, Causes Apoptosis of Human Esophageal Squamous Cell Carcinoma Cells Through ROS-Mediated JNK/P38 MAPK Pathways. Int J Mol Sci 2020;21:E4640. [PMID: 32629820 DOI: 10.3390/ijms21134640] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
260 Anderson JL, Newman NB, Anderson C, Sherry AD, Yock AD, Osmundson EC. Mean cardiopulmonary dose and vertebral marrow dose differentially predict lineage-specific leukopenia kinetics during radiotherapy for esophageal cancer. Radiother Oncol 2020;152:169-76. [PMID: 32291110 DOI: 10.1016/j.radonc.2019.12.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
261 Yang Z, Hui Y, Peng H, Zhang H, Li M, Song L, Li F, Cui X. Identification of a PLCE1‑regulated competing endogenous RNA regulatory network for esophageal squamous cell carcinoma. Oncol Rep 2021;45:857-68. [PMID: 33650665 DOI: 10.3892/or.2021.7921] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
262 Zhong X, Huang G, Ma Q, Liao H, Liu C, Pu W, Xu L, Cai Y, Guo X. Identification of crucial miRNAs and genes in esophageal squamous cell carcinoma by miRNA-mRNA integrated analysis. Medicine (Baltimore) 2019;98:e16269. [PMID: 31277149 DOI: 10.1097/MD.0000000000016269] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
263 Mi X, Xu R, Hong S, Xu T, Zhang W, Liu M. M2 Macrophage-Derived Exosomal lncRNA AFAP1-AS1 and MicroRNA-26a Affect Cell Migration and Metastasis in Esophageal Cancer. Mol Ther Nucleic Acids 2020;22:779-90. [PMID: 33230475 DOI: 10.1016/j.omtn.2020.09.035] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
264 Shi Z, Li G, Li Z, Liu J, Tang Y. TMEM161B-AS1 suppresses proliferation, invasion and glycolysis by targeting miR-23a-3p/HIF1AN signal axis in oesophageal squamous cell carcinoma. J Cell Mol Med 2021;25:6535-49. [PMID: 34046994 DOI: 10.1111/jcmm.16652] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
265 Dai F, Liu T, Zheng S, Liu Q, Yang C, Zhou J, Chen Y, Sheyhidin I, Lu X. MiR-106b promotes migration and invasion through enhancing EMT via downregulation of Smad 7 in Kazakh’s esophageal squamous cell carcinoma. Tumor Biol 2016;37:14595-604. [DOI: 10.1007/s13277-016-5338-x] [Reference Citation Analysis]
266 Triadafilopoulos G, Akiyama J. Emerging endoscopic techniques for the identification of esophageal disease. Expert Rev Gastroenterol Hepatol 2016;10:605-13. [PMID: 26753504 DOI: 10.1586/17474124.2016.1140037] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
267 Mao N, Nie S, Hong B, Li C, Shen X, Xiong T. Association between alcohol dehydrogenase-2 gene polymorphism and esophageal cancer risk: a meta-analysis. World J Surg Oncol 2016;14:191. [PMID: 27450204 DOI: 10.1186/s12957-016-0937-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
268 Zhang X, Jiang Y, Wang Y, Wang Z, Zhao L, Xue X, Sang S, Zhang L. Prognostic role of neutrophil-lymphocyte ratio in esophageal cancer: A systematic review and meta-analysis. Medicine (Baltimore) 2018;97:e13585. [PMID: 30544482 DOI: 10.1097/MD.0000000000013585] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
269 Zhu J, Li H, Ma J, Huang H, Qin J, Li Y. PTPN9 promotes cell proliferation and invasion in Eca109 cells and is negatively regulated by microRNA-126. Oncol Lett 2017;14:1419-26. [PMID: 28789358 DOI: 10.3892/ol.2017.6315] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
270 Shi Q, Diao Y, Jin F, Ding Z. Anti‑metastatic effects of Aidi on human esophageal squamous cell carcinoma by inhibiting epithelial‑mesenchymal transition and angiogenesis. Mol Med Rep 2018;18:131-8. [PMID: 29749455 DOI: 10.3892/mmr.2018.8976] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
271 Tan X, Peng H, Gu P, Chen M, Wang Y. Prognostic Significance of the L3 Skeletal Muscle Index and Advanced Lung Cancer Inflammation Index in Elderly Patients with Esophageal Cancer. Cancer Manag Res 2021;13:3133-43. [PMID: 33859499 DOI: 10.2147/CMAR.S304996] [Reference Citation Analysis]
272 Wu C, Wang Z, Tian X, Wang J, Zhang Y, Wu B. Long non-coding RNA DDX11-AS1 promotes esophageal carcinoma cell proliferation and migration through regulating the miR-514b-3p/RBX1 axis. Bioengineered 2021;12:3772-86. [PMID: 34281459 DOI: 10.1080/21655979.2021.1940617] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
273 Wang Q, Lv Q, Bian H, Yang L, Guo KL, Ye SS, Dong XF, Tao LL. A novel tumor suppressor SPINK5 targets Wnt/β-catenin signaling pathway in esophageal cancer. Cancer Med 2019;8:2360-71. [PMID: 30868765 DOI: 10.1002/cam4.2078] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
274 Hu Z, Xie J, Chen X, Tang J, Zhou K, Han S. Identification of an Immune-Related Biomarker Model Based on the CircRNA-Associated Regulatory Network for Esophageal Carcinoma. J Oncol 2021;2021:1334571. [PMID: 34840568 DOI: 10.1155/2021/1334571] [Reference Citation Analysis]
275 Juo YY, Gibbons MAM, Dutson E, Lin AY, Yanagawa J, Hines OJ, Eibl G, Chen Y. Obesity Is Associated with Early Onset of Gastrointestinal Cancers in California. J Obes. 2018;2018:7014073. [PMID: 30327727 DOI: 10.1155/2018/7014073] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
276 Naeli P, Pourhanifeh MH, Karimzadeh MR, Shabaninejad Z, Movahedpour A, Tarrahimofrad H, Mirzaei HR, Bafrani HH, Savardashtaki A, Mirzaei H, Hamblin MR. Circular RNAs and gastrointestinal cancers: Epigenetic regulators with a prognostic and therapeutic role. Crit Rev Oncol Hematol 2020;145:102854. [PMID: 31877535 DOI: 10.1016/j.critrevonc.2019.102854] [Cited by in Crossref: 83] [Cited by in F6Publishing: 85] [Article Influence: 27.7] [Reference Citation Analysis]
277 Yao S, Wang X, Li C, Zhao T, Jin H, Fang W. Kaempferol inhibits cell proliferation and glycolysis in esophagus squamous cell carcinoma via targeting EGFR signaling pathway. Tumour Biol. 2016;37:10247-10256. [PMID: 26831667 DOI: 10.1007/s13277-016-4912-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
278 Michalinos A, Antoniou SA, Ntourakis D, Schizas D, Ekmektzoglou K, Angouridis A, Johnson EO. Gastric ischemic preconditioning may reduce the incidence and severity of anastomotic leakage after οesophagectomy: a systematic review and meta-analysis. Dis Esophagus 2020;33:doaa010. [PMID: 32372088 DOI: 10.1093/dote/doaa010] [Reference Citation Analysis]
279 Luo W, Liu W, Yao J, Zhu W, Zhang H, Sheng Q, Wang L, Lv L, Qian L. Downregulation of H19 decreases the radioresistance in esophageal squamous cell carcinoma cells. Onco Targets Ther 2019;12:4779-88. [PMID: 31417277 DOI: 10.2147/OTT.S203235] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
280 Yang Y, Chen H, Wang R, Tang Y, Chen X. Cost-Effectiveness Analysis on Endoscopic Surveillance Among Western Patients With Barrett's Esophagus for Esophageal Adenocarcinoma Screening. Medicine 2015;94:e1563. [DOI: 10.1097/md.0000000000001563] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
281 Li Y, Wu G, Yang W, Wang X, Duan L, Niu L, Zhang Y, Liu J, Hong L, Fan D. Prognostic value of circulating tumor cells detected with the CellSearch system in esophageal cancer patients: a systematic review and meta-analysis. BMC Cancer 2020;20:581. [PMID: 32571299 DOI: 10.1186/s12885-020-07059-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
282 Leung G, Mizrahi J, Quintero S, Sosa D, Parkinson D, Taub E, Desai D, Cheng E. Endoscopic Evaluation of Radiologic Distal Esophageal Thickening. J Clin Gastroenterol 2021;55:766-71. [PMID: 32960818 DOI: 10.1097/MCG.0000000000001425] [Reference Citation Analysis]
283 Hassan MS, Awasthi N, Li J, Schwarz MA, Schwarz RE, von Holzen U. A novel intraperitoneal metastatic xenograft mouse model for survival outcome assessment of esophageal adenocarcinoma. PLoS One 2017;12:e0171824. [PMID: 28225784 DOI: 10.1371/journal.pone.0171824] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
284 Dong Z, Wang J, Zhang H, Zhan T, Chen Y, Xu S. Identification of potential key genes in esophageal adenocarcinoma using bioinformatics. Exp Ther Med 2019;18:3291-8. [PMID: 31616504 DOI: 10.3892/etm.2019.7973] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
285 Liu G, Zhao Y, Chen H, Jia J, Cheng X, Wang F, Ji Q, Thorne RF, Chen S, Liu X. Analysis of Differentially Expressed Genes in a Chinese Cohort of Esophageal Squamous Cell Carcinoma. J Cancer 2020;11:3783-93. [PMID: 32328183 DOI: 10.7150/jca.40850] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
286 Adachi Y, Nojima M, Mori M, Yamashita K, Yamano HO, Nakase H, Endo T, Wakai K, Sakata K, Tamakoshi A. Insulin-like growth factor-1, IGF binding protein-3, and the risk of esophageal cancer in a nested case-control study. World J Gastroenterol 2017; 23(19): 3488-3495 [PMID: 28596684 DOI: 10.3748/wjg.v23.i19.3488] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
287 Makino H, Yoshida H, Maruyama H, Yokoyama T, Hirakata A, Ueda J, Takada H, Matsutani T, Nomura T, Hagiwara N, Uchida E. An original technique for lymph node dissection along the left recurrent laryngeal nerve after stripping the residual esophagus during video-assisted thorocoscopic surgery of esophagus. J Vis Surg 2016;2:166. [PMID: 29078551 DOI: 10.21037/jovs.2016.11.01] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
288 Zhang YH, Guo LJ, Yuan XL, Hu B. Artificial intelligence-assisted esophageal cancer management: Now and future. World J Gastroenterol 2020; 26(35): 5256-5271 [PMID: 32994686 DOI: 10.3748/wjg.v26.i35.5256] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
289 Kumar S, Metz DC, Ginsberg GG, Kaplan DE, Goldberg DS. Oesophageal and proximal gastric adenocarcinomas are rare after detection of Helicobacter pylori infection. Aliment Pharmacol Ther 2020;51:781-8. [PMID: 32133681 DOI: 10.1111/apt.15677] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 6.5] [Reference Citation Analysis]
290 Guo Q, Peng Y, Yang H, Guo J. Prognostic Nomogram for Postoperative Patients With Gastroesophageal Junction Cancer of No Distant Metastasis. Front Oncol 2021;11:643261. [PMID: 33937047 DOI: 10.3389/fonc.2021.643261] [Reference Citation Analysis]
291 Gao M, Guo R, Lu X, Xu G, Luo S. Propofol suppresses hypoxia-induced esophageal cancer cell migration, invasion, and EMT through regulating lncRNA TMPO-AS1/miR-498 axis. Thorac Cancer 2020;11:2398-405. [PMID: 32643321 DOI: 10.1111/1759-7714.13534] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
292 Goense L, Meziani J, van Rossum PS, Wessels FJ, Meijer GJ, Lam MG, van Hillegersberg R, Ruurda JP. Limited additional value of cervical ultrasonography over a negative 18F-FDG PET/CT for diagnosing cervical lymph node metastases in patients with esophageal cancer: a systematic review and meta-analysis. Nuclear Medicine Communications 2018;39:645-51. [DOI: 10.1097/mnm.0000000000000847] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
293 Naik KB, Liu Y, Goodman M, Gillespie TW, Pickens A, Force SD, Steuer CE, Owonikoko TK, Ramalingam SS, Higgins K, Beitler JJ, Shin DM, Willingham FF, El-Rayes B, Landry JC, Fernandez FG, Saba NF. Concurrent chemoradiotherapy with or without surgery for patients with resectable esophageal cancer: An analysis of the National Cancer Data Base. Cancer 2017;123:3476-85. [PMID: 28464264 DOI: 10.1002/cncr.30763] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
294 Hamel C, Ahmadzai N, Beck A, Thuku M, Skidmore B, Pussegoda K, Bjerre L, Chatterjee A, Dennis K, Ferri L, Maziak DE, Shea BJ, Hutton B, Little J, Moher D, Stevens A. Screening for esophageal adenocarcinoma and precancerous conditions (dysplasia and Barrett's esophagus) in patients with chronic gastroesophageal reflux disease with or without other risk factors: two systematic reviews and one overview of reviews to inform a guideline of the Canadian Task Force on Preventive Health Care (CTFPHC). Syst Rev 2020;9:20. [PMID: 31996261 DOI: 10.1186/s13643-020-1275-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
295 Wang J, Xie X, Sun Y. Time series expression pattern of key genes reveals the molecular process of esophageal cancer. Biosci Rep 2020;40:BSR20191985. [PMID: 32068233 DOI: 10.1042/BSR20191985] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
296 Li B, Liu Y, Peng J, Sun C, Rang W. Trends of Esophageal Cancer Incidence and Mortality and Its Influencing Factors in China. Risk Manag Healthc Policy 2021;14:4809-21. [PMID: 34876863 DOI: 10.2147/RMHP.S312790] [Reference Citation Analysis]
297 Moon H, Zhu J, Donahue LR, Choi E, White AC. Krt5+/Krt15+ foregut basal progenitors give rise to cyclooxygenase-2-dependent tumours in response to gastric acid stress. Nat Commun 2019;10:2225. [PMID: 31110179 DOI: 10.1038/s41467-019-10194-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
298 Ferrer-Torres D, Nancarrow DJ, Steinberg H, Wang Z, Kuick R, Weh KM, Mills RE, Ray D, Ray P, Lin J, Chang AC, Reddy RM, Orringer MB, Canto MI, Shaheen NJ, Kresty LA, Chak A, Wang TD, Rubenstein JH, Beer DG. Constitutively Higher Level of GSTT2 in Esophageal Tissues From African Americans Protects Cells Against DNA Damage. Gastroenterology 2019;156:1404-15. [PMID: 30578782 DOI: 10.1053/j.gastro.2018.12.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
299 Wang H, Yu J, Guo Y, Zhang Z, Liu G, Li J, Zhang X, Jin T, Wang Z. Genetic variants in the ZNF208 gene are associated with esophageal cancer in a Chinese Han population. Oncotarget 2016;7:86829-35. [PMID: 27907911 DOI: 10.18632/oncotarget.13468] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
300 Siddiqui AZ, Almhanna K. Beyond Chemotherapy, PD-1, and HER-2: Novel Targets for Gastric and Esophageal Cancer. Cancers (Basel) 2021;13:4322. [PMID: 34503132 DOI: 10.3390/cancers13174322] [Reference Citation Analysis]
301 Wang B, Tang D, Liu Z, Wang Q, Xue S, Zhao Z, Feng D, Sheng C, Li J, Zhou Z. LINC00958 promotes proliferation, migration, invasion, and epithelial-mesenchymal transition of oesophageal squamous cell carcinoma cells. PLoS One 2021;16:e0251797. [PMID: 34003875 DOI: 10.1371/journal.pone.0251797] [Reference Citation Analysis]
302 Hou TC, Dai KY, Wu MC, Hua KL, Tai HC, Huang WC, Chen YJ. Bio-physic constraint model using spatial registration of delta 18F-fluorodeoxyglucose positron emission tomography/computed tomography images for predicting radiation pneumonitis in esophageal squamous cell carcinoma patients receiving neoadjuvant chemoradiation. Onco Targets Ther 2019;12:6439-51. [PMID: 31496743 DOI: 10.2147/OTT.S205803] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
303 Tungekar A, Mandarthi S, Mandaviya PR, Gadekar VP, Tantry A, Kotian S, Reddy J, Prabha D, Bhat S, Sahay S, Mascarenhas R, Badkillaya RR, Nagasampige MK, Yelnadu M, Pawar H, Hebbar P, Kashyap MK. ESCC ATLAS: A population wide compendium of biomarkers for Esophageal Squamous Cell Carcinoma. Sci Rep 2018;8:12715. [PMID: 30143675 DOI: 10.1038/s41598-018-30579-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
304 Syed A, Maradey-Romero C, Fass R. The relationship between eosinophilic esophagitis and esophageal cancer. Dis Esophagus 2017;30:1-5. [PMID: 30052901 DOI: 10.1093/dote/dox050] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
305 Cavallin F, Alfieri R, Scarpa M, Cagol M, Ruol A, Fassan M, Rugge M, Ancona E, Castoro C. Nodal skip metastasis in thoracic esophageal squamous cell carcinoma: a cohort study. BMC Surg 2017;17:49. [PMID: 28464907 DOI: 10.1186/s12893-017-0247-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
306 Laszkowska M, Oh A, Hur C. Screening for Upper Gastrointestinal Malignancies in the United States-Which Immigrant Groups Should Be Considered High-Risk? Gastroenterology 2020;158:4-8. [PMID: 31614125 DOI: 10.1053/j.gastro.2019.09.047] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
307 Wang G, Sun J, Zhao H, Li H. Long Non-Coding RNA (lncRNA) Growth Arrest Specific 5 (GAS5) Suppresses Esophageal Squamous Cell Carcinoma Cell Proliferation and Migration by Inactivating Phosphatidylinositol 3-kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Signaling Pathway. Med Sci Monit 2018;24:7689-96. [PMID: 30368517 DOI: 10.12659/MSM.910867] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
308 Zhou W, Wu J, Liu X, Ni M, Meng Z, Liu S, Jia S, Zhang J, Guo S, Zhang X. Identification of crucial genes correlated with esophageal cancer by integrated high-throughput data analysis. Medicine (Baltimore) 2020;99:e20340. [PMID: 32443386 DOI: 10.1097/MD.0000000000020340] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
309 Bugter O, Li Y, Wolters AHG, Agrawal V, Dravid A, Chang A, Hardillo J, Giepmans BNG, Baatenburg de Jong RJ, Amelink A, Backman V, Robinson DJ. Early Upper Aerodigestive Tract Cancer Detection Using Electron Microscopy to Reveal Chromatin Packing Alterations in Buccal Mucosa Cells. Microsc Microanal 2021;27:878-88. [PMID: 34108070 DOI: 10.1017/S1431927621000507] [Reference Citation Analysis]
310 Zhao C, Lu Q, Gu Y, Pan E, Sun Z, Zhang H, Zhou J, Du Y, Zhang Y, Feng Y, Liu R, Pu Y, Yin L. Distribution of N-nitrosamines in drinking water and human urinary excretions in high incidence area of esophageal cancer in Huai'an, China. Chemosphere 2019;235:288-96. [DOI: 10.1016/j.chemosphere.2019.06.124] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
311 Li CL, Zhao JQ, Zang B. PRKAA1 rs13361707 C/T polymorphism confers decreased susceptibility to esophageal cancer: A case-control study. J Clin Lab Anal 2020;34:e23406. [PMID: 32488984 DOI: 10.1002/jcla.23406] [Reference Citation Analysis]
312 Saeed SM, Naffouje S, Mehta R, Hoffe SE, Fontaine JP, Lauwers GY, Shah P, Frakes J, Pimiento JM. Impact of histology classification on pathologic treatment response and overall survival in distal esophageal cancer patients: a propensity matched analysis. Dis Esophagus 2021;34:doaa099. [PMID: 32996568 DOI: 10.1093/dote/doaa099] [Reference Citation Analysis]
313 Wang L, Li X, Zhao L, Jiang L, Song X, Qi A, Chen T, Ju M, Hu B, Wei M, He M, Zhao L. Identification of DNA-Repair-Related Five-Gene Signature to Predict Prognosis in Patients with Esophageal Cancer. Pathol Oncol Res 2021;27:596899. [PMID: 34257547 DOI: 10.3389/pore.2021.596899] [Reference Citation Analysis]
314 Nieuwenhuis L, van den Brandt PA. Tree nut, peanut, and peanut butter consumption and the risk of gastric and esophageal cancer subtypes: the Netherlands Cohort Study. Gastric Cancer. 2018;21:900-912. [PMID: 29594821 DOI: 10.1007/s10120-018-0821-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
315 Hu R, Bi R, Jiang L, Yang X, Zhong Y, Xie X. LncRNA TUSC8 suppresses the proliferation and migration of esophageal cancer cells by downregulation of VEGFA. J Cancer 2021;12:6393-400. [PMID: 34659529 DOI: 10.7150/jca.57814] [Reference Citation Analysis]
316 Tian D, Mo SJ, Han LK, Cheng L, Huang H, Hao S, Guan YL, Jiang KY, Deng JY, Feng HH, Wen HY, Fu MY. Investigation of Dietary Factors and Esophageal Cancer Knowledge: Comparison of Rural Residents in High- and Low-incidence Areas. Sci Rep. 2018;8:4914. [PMID: 29559669 DOI: 10.1038/s41598-018-23251-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
317 Tian J, Mei X, Guo M, Xiong R, Sun X. Effectiveness of jejunostomy for enteral nutrition during complete thoracoscopic and laparoscopic Ivor-Lewis esophagectomy in thoracic segment esophageal carcinoma. J Cardiothorac Surg 2020;15:142. [PMID: 32552786 DOI: 10.1186/s13019-020-01162-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
318 Patel N, Benipal B. Incidence of Esophageal Cancer in the United States from 2001-2015: A United States Cancer Statistics Analysis of 50 States. Cureus 2018;10:e3709. [PMID: 30788198 DOI: 10.7759/cureus.3709] [Cited by in Crossref: 2] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
319 Zhao J, Jin G, Liu X, Wu K, Yang Y, He Z, Liu D, Zhang C, Zhu D, Jiao J, Li X, Zhao S. PAR1 and PAR4 exert opposite effects on tumor growth and metastasis of esophageal squamous cell carcinoma via STAT3 and NF-κB signaling pathways. Cancer Cell Int 2021;21:637. [PMID: 34844621 DOI: 10.1186/s12935-021-02354-4] [Reference Citation Analysis]
320 Xi Y, Dong W, Qiao L, Han K, Chen W, Wang W. Trends in incidence and mortality of esophageal cancer in Inner Mongolia, 2010-2015. Thorac Cancer 2020;11:2440-8. [PMID: 32716130 DOI: 10.1111/1759-7714.13552] [Reference Citation Analysis]
321 Hou W, Wang L, Cai S, Lin Z, Yu R, Qin J. Early neoplasia identification in Barrett's esophagus via attentive hierarchical aggregation and self-distillation. Med Image Anal 2021;72:102092. [PMID: 34030101 DOI: 10.1016/j.media.2021.102092] [Reference Citation Analysis]
322 Zakko L, Lutzke L, Wang KK. Screening and Preventive Strategies in Esophagogastric Cancer. Surg Oncol Clin N Am 2017;26:163-78. [PMID: 28279462 DOI: 10.1016/j.soc.2016.10.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
323 Wang X, Cheng G, Zhang T, Deng L, Xu K, Xu X, Wang W, Zhou Z, Feng Q, Chen D, Bi N, Wang L. CHST15 promotes the proliferation of TE‑1 cells via multiple pathways in esophageal cancer. Oncol Rep 2020;43:75-86. [PMID: 31746400 DOI: 10.3892/or.2019.7395] [Reference Citation Analysis]
324 Qin Y, Wu CW, Taylor WR, Sawas T, Burger KN, Mahoney DW, Sun Z, Yab TC, Lidgard GP, Allawi HT, Buttar NS, Smyrk TC, Iyer PG, Katzka DA, Ahlquist DA, Kisiel JB. Discovery, Validation, and Application of Novel Methylated DNA Markers for Detection of Esophageal Cancer in Plasma. Clin Cancer Res 2019;25:7396-404. [PMID: 31527170 DOI: 10.1158/1078-0432.CCR-19-0740] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
325 Thein HH, Jembere N, Thavorn K, Chan KKW, Coyte PC, de Oliveira C, Hur C, Earle CC. Estimates and predictors of health care costs of esophageal adenocarcinoma: a population-based cohort study. BMC Cancer. 2018;18:694. [PMID: 29945563 DOI: 10.1186/s12885-018-4620-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
326 Kawahara D, Murakami Y, Tani S, Nagata Y. A prediction model for degree of differentiation for resectable locally advanced esophageal squamous cell carcinoma based on CT images using radiomics and machine-learning. Br J Radiol 2021;94:20210525. [PMID: 34235955 DOI: 10.1259/bjr.20210525] [Reference Citation Analysis]
327 Lyu S, Jiang C, Xu R, Huang Y, Yan S. INHBA upregulation correlates with poorer prognosis in patients with esophageal squamous cell carcinoma. Cancer Manag Res 2018;10:1585-96. [PMID: 29950896 DOI: 10.2147/CMAR.S160186] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
328 Qu J, Wang CC, Cai SB, Zhao WD, Cheng XL, Ming Z. Biased Random Walk With Restart on Multilayer Heterogeneous Networks for MiRNA-Disease Association Prediction. Front Genet 2021;12:720327. [PMID: 34447416 DOI: 10.3389/fgene.2021.720327] [Reference Citation Analysis]
329 Hassan MS, Cwidak N, Johnson C, Däster S, Eppenberger-Castori S, Awasthi N, Li J, Schwarz MA, von Holzen U. Therapeutic Potential of the Cyclin-Dependent Kinase Inhibitor Flavopiridol on c-Myc Overexpressing Esophageal Cancer. Front Pharmacol 2021;12:746385. [PMID: 34621175 DOI: 10.3389/fphar.2021.746385] [Reference Citation Analysis]
330 Zhao W, Huang Z, Liu H, Wang C. LncRNA GIHCG Promotes the Development of Esophageal Cancer by Modulating miR-29b-3p/ANO1 Axis. Onco Targets Ther 2020;13:13387-400. [PMID: 33408485 DOI: 10.2147/OTT.S282348] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
331 Wang X, Zhao Y, Lu Q, Fei X, Lu C, Li C, Chen H. MiR-34a-5p Inhibits Proliferation, Migration, Invasion and Epithelial-mesenchymal Transition in Esophageal Squamous Cell Carcinoma by Targeting LEF1 and Inactivation of the Hippo-YAP1/TAZ Signaling Pathway. J Cancer 2020;11:3072-81. [PMID: 32226522 DOI: 10.7150/jca.39861] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 6.5] [Reference Citation Analysis]
332 Yuan Y, Zhao Z, Xue L, Wang G, Song H, Pang R, Zhou J, Luo J, Song Y, Yin Y. Identification of diagnostic markers and lipid dysregulation in oesophageal squamous cell carcinoma through lipidomic analysis and machine learning. Br J Cancer 2021;125:351-7. [PMID: 33953345 DOI: 10.1038/s41416-021-01395-w] [Reference Citation Analysis]
333 Huang P, Sun LY, Zhang YQ. A Hopeful Natural Product, Pristimerin, Induces Apoptosis, Cell Cycle Arrest, and Autophagy in Esophageal Cancer Cells. Anal Cell Pathol (Amst) 2019;2019:6127169. [PMID: 31218209 DOI: 10.1155/2019/6127169] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
334 Du W, Rao N, Dong C, Wang Y, Hu D, Zhu L, Zeng B, Gan T. Automatic classification of esophageal disease in gastroscopic images using an efficient channel attention deep dense convolutional neural network. Biomed Opt Express 2021;12:3066-81. [PMID: 34221645 DOI: 10.1364/BOE.420935] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
335 Triadafilopoulos G, Clarke J, Hawn M. Whole greater than the parts: integrated esophageal centers (IEC) and advanced training in esophageal diseases. Dis Esophagus 2017;30:1-9. [PMID: 28859396 DOI: 10.1093/dote/dox084] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
336 Peng L, Sun C, Guan N, Li J, Chen X. HNMDA: heterogeneous network-based miRNA–disease association prediction. Mol Genet Genomics 2018;293:983-95. [DOI: 10.1007/s00438-018-1438-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
337 Huang M, Xu MT, Wang GL, Han M, Chen X, Wen JB. Relationship of expression of heat shock transcription factor 1 with sensitivity to radiotherapy and chemotherapy in esophageal squamous cell carcinoma. Shijie Huaren Xiaohua Zazhi 2021; 29(14): 775-787 [DOI: 10.11569/wcjd.v29.i14.775] [Reference Citation Analysis]
338 Li F, Wang H, Hou J, Tang J, Lu Q, Wang L, Yu X. Utility of intravoxel incoherent motion diffusion-weighted imaging in predicting early response to concurrent chemoradiotherapy in oesophageal squamous cell carcinoma. Clinical Radiology 2018;73:756.e17-26. [DOI: 10.1016/j.crad.2018.03.015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
339 Bolm L, Cigolla S, Wittel UA, Hopt UT, Keck T, Rades D, Bronsert P, Wellner UF. The Role of Fibroblasts in Pancreatic Cancer: Extracellular Matrix Versus Paracrine Factors. Transl Oncol 2017;10:578-88. [PMID: 28658650 DOI: 10.1016/j.tranon.2017.04.009] [Cited by in Crossref: 18] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]
340 Yang H, Zhang S, Yan H, Wang J, Fan J, Qiao Y, Taylor PR. Fresh fruit consumption may decrease the long-term risk of esophageal cancer mortality: A 30-year follow-up study in the Linxian Dysplasia Nutrition Intervention trial (NIT). Thorac Cancer 2020;11:1918-26. [PMID: 32469462 DOI: 10.1111/1759-7714.13482] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
341 Nesteruk K, Spaander MCW, Leeuwenburgh I, Peppelenbosch MP, Fuhler GM. Achalasia and associated esophageal cancer risk: What lessons can we learn from the molecular analysis of Barrett's-associated adenocarcinoma? Biochim Biophys Acta Rev Cancer 2019;1872:188291. [PMID: 31059738 DOI: 10.1016/j.bbcan.2019.04.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
342 Sarkar S, Datta D, Debbarma S, Majumdar G, Mandal SS. Patterns of Cancer Incidence and Mortality in North- Eastern India: The First Report from the Population Based Cancer Registry of Tripura. Asian Pac J Cancer Prev 2020;21:2493-9. [PMID: 32986344 DOI: 10.31557/APJCP.2020.21.9.2493] [Reference Citation Analysis]
343 Anderluh F, Toplak M, Velenik V, Oblak I, Ermenc AS, Peressutti AJ, But-Hadzic J, Vidmar MS. Definitive radiochemotherapy in esophageal cancer - a single institution experience. Radiol Oncol 2019;53:480-7. [PMID: 31747382 DOI: 10.2478/raon-2019-0054] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
344 Testa A, Venturelli E, Brizzi MF. Extracellular Vesicles as a Novel Liquid Biopsy-Based Diagnosis for the Central Nervous System, Head and Neck, Lung, and Gastrointestinal Cancers: Current and Future Perspectives. Cancers (Basel) 2021;13:2792. [PMID: 34205183 DOI: 10.3390/cancers13112792] [Reference Citation Analysis]
345 Liu S, Huang M, Chen Z, Chen J, Chao Q, Yin X, Quan M. FTO promotes cell proliferation and migration in esophageal squamous cell carcinoma through up-regulation of MMP13. Exp Cell Res 2020;389:111894. [PMID: 32035950 DOI: 10.1016/j.yexcr.2020.111894] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
346 Diaz LI, Mony S, Klapman J. Narrative review of the role of gastroenterologist in the diagnosis, treatment and palliation in gastric and gastroesophageal cancer. Ann Transl Med 2020;8:1106. [PMID: 33145325 DOI: 10.21037/atm-20-4143] [Reference Citation Analysis]
347 Zang B, Chen C, Zhao JQ. PD-1 gene rs10204525 and rs7421861 polymorphisms are associated with increased risk and clinical features of esophageal cancer in a Chinese Han population. Aging (Albany NY) 2020;12:3771-90. [PMID: 32084010 DOI: 10.18632/aging.102845] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
348 Wang Y, Zhang X, Jiang Y, Ma G, Wang Z, Xue X, Sang S, Zhang L. Comparison of hand-sewn versus mechanical esophagogastric anastomosis in esophageal cancer: Protocol for a systematic review and meta-analysis. Medicine (Baltimore) 2019;98:e15676. [PMID: 31169669 DOI: 10.1097/MD.0000000000015676] [Reference Citation Analysis]
349 Guo X, Meng X, Liu R. Prognostic value of microvessel density in esophageal squamous cell carcinoma-a systematic review and meta-analysis. Pathol Res Pract 2021;227:153644. [PMID: 34634564 DOI: 10.1016/j.prp.2021.153644] [Reference Citation Analysis]
350 Kohli N, Blitzer A, Jahn A, Cho YJ, Budrewicz J, Enos K, Strome M. Safety and Feasibility of a Novel Esophageal Balloon for Circumferential Cytologic Sampling. Ann Otol Rhinol Laryngol 2021;130:585-90. [PMID: 33412926 DOI: 10.1177/0003489420964831] [Reference Citation Analysis]
351 Dai F, Mei L, Meng S, Ma Z, Guo W, Zhou J, Zhang J. The global expression profiling in esophageal squamous cell carcinoma. Genomics 2017;109:241-50. [DOI: 10.1016/j.ygeno.2017.04.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
352 Zhang Y, Zhang L, Wang R, Wang B, Hua P, Li J. LncRNA Erbb4‐IR promotes esophageal squamous cell carcinoma (ESCC) by downregulating miR‐145. J Cell Biochem 2019;120:17566-72. [DOI: 10.1002/jcb.29023] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
353 Yang W, Ma J, Zhou W, Zhou X, Cao B, Zhang H, Zhao Q, Fan D, Hong L. Molecular mechanisms and clinical implications of miRNAs in drug resistance of esophageal cancer. Expert Rev Gastroenterol Hepatol 2017;11:1151-63. [PMID: 28838272 DOI: 10.1080/17474124.2017.1372189] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
354 Jia Y, Yan X, Cao Y, Song W, Zhang G, Hu X. Anticancer Activity of Modified Tongyou Decoction on Eca109 Esophageal Cancer Cell Invasion and Metastasis through Regulation of the Epithelial-Mesenchymal Transition Mediated by the HIF-1α-Snail Axis. Evid Based Complement Alternat Med 2020;2020:3053506. [PMID: 33062005 DOI: 10.1155/2020/3053506] [Reference Citation Analysis]
355 Wu H, Zhuang W, Huang S, Guan X, Zheng Y, Xie Z, Chen G, Tang J, Zhou H, Xie L, Ben X, Zhou Z, Li Z, Chen R, Qiao G. Optimal Range of Lymphadenectomy in Pathological Stage T1 and T2 Esophageal Squamous Cell Carcinoma. Front Oncol 2021;11:619556. [PMID: 34113556 DOI: 10.3389/fonc.2021.619556] [Reference Citation Analysis]
356 Xu S, Li X, Li L, Wang Y, Geng C, Guo F, Zhang T, Du A, Lu Z, Hui H, Wang Q. CTCF-silenced miR-137 contributes to EMT and radioresistance in esophageal squamous cell carcinoma. Cancer Cell Int 2021;21:155. [PMID: 33685449 DOI: 10.1186/s12935-020-01740-8] [Reference Citation Analysis]
357 Zou S, Yang J, Guo J, Su Y, He C, Wu J, Yu L, Ding W, Zhou J. RAD18 promotes the migration and invasion of esophageal squamous cell cancer via the JNK-MMPs pathway. Cancer Letters 2018;417:65-74. [DOI: 10.1016/j.canlet.2017.12.034] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
358 Santo ATDE, Siqueira LM, Almeida RN, Vargas RMF, Franceschini GDN, Kunde MA, Cappellari AR, Morrone FB, Cassel E. Decaffeination of yerba mate by supercritical fluid extraction: Improvement, mathematical modelling and infusion analysis. The Journal of Supercritical Fluids 2021;168:105096. [DOI: 10.1016/j.supflu.2020.105096] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
359 Jiao R, Luo H, Xu W, Ge H. Immune checkpoint inhibitors in esophageal squamous cell carcinoma: progress and opportunities. Onco Targets Ther 2019;12:6023-32. [PMID: 31551657 DOI: 10.2147/OTT.S214579] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
360 Qiao G, Zhuang W, Dong B, Li C, Xu J, Wang G, Xie L, Zhou Z, Tian D, Chen G, Tang J, Zhou H, Zhang D, Shi R, Chen R, Nian W, Zhang Y, Zhao J, Wen X, Xu Y, Li B, Zhang Z, Cai S, Ben X, Qi Y. Discovery and validation of methylation signatures in circulating cell-free DNA for early detection of esophageal cancer: a case-control study. BMC Med 2021;19:243. [PMID: 34641873 DOI: 10.1186/s12916-021-02109-y] [Reference Citation Analysis]
361 Jin W, Luo W, Fang W, Wang Y, Wang L, Shen Q, Liu W, Zhang H. miR-145 expression level in tissue predicts prognosis of patients with esophageal squamous cell carcinoma. Pathol Res Pract 2019;215:152401. [PMID: 31014553 DOI: 10.1016/j.prp.2019.03.029] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
362 Yamazaki T, Iwaya Y, Iwaya M, Watanabe T, Seki A, Ochi Y, Hara E, Sekiguchi T, Hosaka N, Arakura N, Tanaka E, Hasebe O. A case of simultaneous esophageal squamous cell carcinoma and Barrett’s adenocarcinoma. Clin J Gastroenterol 2016;9:222-7. [DOI: 10.1007/s12328-016-0653-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
363 Lu HH, Chiu NC, Tsai MH. Prognostic Significance of Pretreatment Staging With 18F-FDG PET in Esophageal Cancer: A Nationwide Population-Based Study. Clin Nucl Med 2021;46:647-53. [PMID: 34034334 DOI: 10.1097/RLU.0000000000003739] [Reference Citation Analysis]
364 Wang T, Wang J, Ren W, Liu ZL, Cheng YF, Zhang XM. Combination treatment with artemisinin and oxaliplatin inhibits tumorigenesis in esophageal cancer EC109 cell through Wnt/β-catenin signaling pathway. Thorac Cancer 2020;11:2316-24. [PMID: 32657048 DOI: 10.1111/1759-7714.13570] [Reference Citation Analysis]
365 Li J, Ye D, Wang L, Peng Y, Li Q, Deng H, Zhou C. Role of MLH1 methylation in esophageal cancer carcinogenesis and its clinical significance. Onco Targets Ther 2018;11:651-63. [PMID: 29440913 DOI: 10.2147/OTT.S154999] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
366 Zhou Y, Chu L, Wang Q, Dai W, Zhang X, Chen J, Li L, Ding P, Zhang L, Gu H, Li L, Lv X, Zhang W, Zhou D, Zhang P, Cai G, Zhao K, Hu W. CD59 is a potential biomarker of esophageal squamous cell carcinoma radioresistance by affecting DNA repair. Cell Death Dis 2018;9:887. [PMID: 30166523 DOI: 10.1038/s41419-018-0895-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
367 Yang X, Suo C, Zhang T, Yin X, Man J, Yuan Z, Chen H, Yu J, Jin L, Chen X, Lu M, Ye W. A nomogram for screening esophageal squamous cell carcinoma based on environmental risk factors in a high-incidence area of China: a population-based case-control study. BMC Cancer 2021;21:343. [PMID: 33789604 DOI: 10.1186/s12885-021-08053-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
368 Yusupbekov A, Kanda M, Usmanov B, Tuychiev O, Baymakov S, Sakamoto J, Yusupbekov A. Surveillance of Esophageal Cancer in the Republic of Uzbekistan from 2000 to 2018. Asian Pac J Cancer Prev 2020;21:2281-5. [PMID: 32856856 DOI: 10.31557/APJCP.2020.21.8.2281] [Reference Citation Analysis]
369 Lian X, Zhu C, Lin H, Gao Z, Li G, Zhang N, Cao B, Kang Y. Radiosensitization of HER2-positive esophageal cancer cells by pyrotinib. Biosci Rep 2020;40:BSR20194167. [PMID: 32022229 DOI: 10.1042/BSR20194167] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
370 Liu Y. Artificial intelligence-assisted endoscopic detection of esophageal neoplasia in early stage: The next step? World J Gastroenterol 2021; 27(14): 1392-1405 [PMID: 33911463 DOI: 10.3748/wjg.v27.i14.1392] [Reference Citation Analysis]
371 Ghaffar M, Khodahemmati S, Li J, Shahzad M, Wang M, Wang Y, Li C, Chen S, Zeng Y. Long Non-coding RNA LINC01234 Regulates Proliferation, Invasion and Apoptosis in Esophageal Cancer Cells. J Cancer 2018;9:4242-9. [PMID: 30519325 DOI: 10.7150/jca.26095] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
372 Sawyer WP, Luo X, Welch AM, Bolton NM, Brown R, Bolton JS. 15-Year Experience with Multimodality Therapy Including Esophagectomy for Elderly Patients with Locoregional Esophageal Cancer. J Am Coll Surg 2021;232:580-8. [PMID: 33549634 DOI: 10.1016/j.jamcollsurg.2020.11.027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
373 Goh KJ, Lee P, Foo AZX, Tan EH, Ong HS, Hsu AAL. Characteristics and Outcomes of Airway Involvement in Esophageal Cancer. Ann Thorac Surg 2021;112:912-20. [PMID: 33161017 DOI: 10.1016/j.athoracsur.2020.10.015] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
374 Ibuki Y, Nishiyama Y, Tsutani Y, Emi M, Hamai Y, Okada M, Tahara H. Circulating microRNA/isomiRs as novel biomarkers of esophageal squamous cell carcinoma. PLoS One 2020;15:e0231116. [PMID: 32251457 DOI: 10.1371/journal.pone.0231116] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
375 Boldrin E, Piano MA, Alfieri R, Mazza M, Vassallo L, Scapinello A, Pilati P, Curtarello M. MSI Analysis in Solid and Liquid Biopsies of Gastroesophageal Adenocarcinoma Patients: A Molecular Approach. Int J Mol Sci 2021;22:7244. [PMID: 34298864 DOI: 10.3390/ijms22147244] [Reference Citation Analysis]
376 Niu Z, Zhang W, Shi J, Li X, Wu H. Effect of silencing C-erbB-2 on esophageal carcinoma cell biological behaviors by inhibiting IGF-1 pathway activation. J Cardiothorac Surg 2021;16:194. [PMID: 34233689 DOI: 10.1186/s13019-021-01540-9] [Reference Citation Analysis]
377 Meyer C, Hejazi R, Bansal A. How extent of Barrett's metaplasia influences the risk of esophageal adenocarcinoma. Curr Opin Gastroenterol 2021;37:378-83. [PMID: 33883421 DOI: 10.1097/MOG.0000000000000743] [Reference Citation Analysis]